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ABSTRACT 
 
 
 
Traumatic injuries or cancer irradiation can cause critical sized defects in long bones. 
Regeneration capabilities of most mammals in their long bones are robust in small defects such as 
fractures but diminish in large defects due to lack of proper cellular cues. A small animal in vivo model 
has been developed to study the effect of two biocompatible scaffolds, an artificial polymer scaffold 
(HDDA) and a protein (zein) scaffold, on regeneration of long bone defects in adult African Clawed 
Frogs (Xenopus laevis) hind limbs. The HDDA scaffolds loaded with growth factors BMP4 and VEGF 
and zein scaffolds loaded with growth factors BMP4 and FGF10 were implanted in the critical defect site 
in the tarsus of the Xenopus Laevis. Defects in control frogs were left empty. Fractures were also induced 
in some frogs to study the mechanisms of endochondral ossification. The limbs were harvested at a series 
of early time points ranging from 3 days to 6 weeks after implantation.  Standard histology was used to 
evaluate tissue types and the anatomical relationships.  In frogs treated with growth factor-soaked HDDA 
scaffolds, the defect site was completely filled with cartilage by 3 weeks showing a biological response 
which appeared to be similar to the fracture healing mechanism. In frogs treated with growth factor-
soaked zein scaffolds, the defect site was partially bridged by cartilage and was filled with a large wound-
healing immune response. Blood vessels had invaded the cartilage and a response also similar to fracture 
healing was observed.  Histology in the early time points has shown a vast amount of vascular in-growth 
at 1 week and the beginning of cartilage formation as early as 2 weeks in the scaffold-implanted defects. 
In contrast, defects in control frogs showed formation of fibrous scar tissue and negligible cartilage 
formation.  These studies demonstrate the feasibility of using scaffolds loaded with carefully selected 
growth factors to repair long bone defects over gaps of critical size by fracture healing and developmental 
regeneration mechanisms. 
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Chapter 1: Introduction 
 
Bone is a vital component of the human body especially for functions such as movement, support, 
protection, blood cell production, mineral homeostasis and triglyceride storage amongst many others. 
Bone is also a very complex and dynamic living tissue with an intrinsic remodeling capability amongst 
many other properties. Within 2 to 3 months, bone undergoes a full cycle of remodeling by resorption and 
deposition. Bone resorption occurs when osteoclasts, or bone destroying cells, destroy old bone matrix by 
dissolving proteins, collagen fibers, minerals and organic substances. Bone deposition occurs when 
osteoblasts, or bone forming cells, dispense new matrix along lines of mechanical stress [1]. This balance 
between bone resorption and bone deposition maintains homeostasis and drives natural healing when 
there is a small defect in bone such as a fracture. However, when a large defect occurs, the bone 
remodeling process attempts to heal the defect naturally but is unable to do so due to its inability to bridge 
a large gap through rapid cell migration [2]. In this case, intervention is needed through implants such as 
grafts, scaffolds, etc. in order to enhance the healing of a large defect.  
 
 
1.1 Bone Defects 
 
 
There are many types of bone defects that may occur due to events such as excessive mechanical 
loading, disease, aging, etc. The most common bone defect is a fracture. A fracture is any small break in a 
bone whereby the bone has the ability to heal itself naturally. It can occur due to large stresses on the 
bone in various directions which define the mode of fracture. For example, torsion of the bone may result 
in a shear fracture. On the other hand, a critical size defect is a large break or void in a bone whereby the 
bone cannot heal itself naturally [2]. In this case, fibrous in-growth occurs, displaying a large amount of 
scar tissue. This may arise due to severe trauma where a large portion of the bone is crushed and 
removed, or it may also occur due to bone irradiation in cancer patients. The critical size defect or CSD of 
mammalian long bones in previous research appears to be equal to or greater than 20% of the length of a 
long bone [3]. Species capable of rapid regeneration including salamanders or other amphibians are also 
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unable to properly repair bone CSDs as adults. Therefore, the length of the bone defect is crucial. If the 
defect in a long bone is large, i.e., greater than 20% of the length of the bone in mammals, natural healing 
via bone remodeling is insufficient to restore lost bone. 
 
Fracture healing is a well-understood bone remodeling process. As a result of a fracture, blood 
vessels, bone units or osteons, the medullary cavity and perforating canals crossing the fracture lines are 
severed. Between 6 and 8 hours post-injury, blood leaks from the two ends of the ruptured vessels 
forming a clot around the site of the fracture known as a fracture hematoma. Circulation of blood stops 
when the hematoma forms and bone cells at the fracture site cease to engage in forming bone, or osseous 
tissue. Cellular debris is scattered and therefore, swelling and inflammation occur in response to dead 
bone cells. During several weeks that follow, blood capillaries form into the clot and immune cells such 
as phagocytes and osteoclasts begin to digest dead and damaged tissue in and around the hematoma. 
Granulation tissue is formed by fibrous, connective tissue during this wound healing process and blood 
capillaries infiltrate the fracture hematoma. Fibroblasts or matrix-forming cells invade the granulation 
tissue. A fibrocartilaginous callus is formed bridging both ends of the bone when fibroblasts produce 
collagen fibers and the osteogenic cells develop into chondroblasts (cartilage forming cells) in areas of 
avascular healthy bone, lasting about 3 weeks during bone repair. This is the process of endochondral 
ossification whereby bone repair is facilitated by initially forming cartilage. After 3 to 4 months, bony 
callus forms, where osteogenic cells mature into osteoblasts or bone-forming cells, laying down 
trabecular bone from fibrocartilage. Finally, osteoclasts digest the debris of the remaining bone and 
compact bone replaces trabecular bone at the fracture site, which is commonly known as woven bone, 
forming a thickened area on the surface of the bone close to the healed fracture. It normally takes years 
for woven bone to transform into original mature lamellar bone [1].  
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Figure 1 (left): The 4 stages of the fracture repair 
- Hematoma, Soft Callus, Hard Callus formation 
and Remodeling [4].  
        
      
 
 
 
 
 
 
 
 
In contrast, very little is known about cellular activity in critical size defects and why critical size 
defects have the inability to repair bone. There have been many investigations involving various methods 
in order to attempt to regenerate bone tissue in CSDs. Many of these studies have used fracture healing as 
a precursor to help repair bone tissue in CSDs. Therefore, it is important to characterize the cellular-, 
gene- and protein-based biological or chemical factors essential for bone formation in naturally healing 
fractured bone in order to induce the same level or remodeling or regeneration in a CSD in bone. 
 
 
1.2 Long Bone Regeneration in Xenopus Laevis 
 
 
Most humans and vertebrates have the capability to regenerate and remodel long bone fractures 
and non-critical size defects to restore structural and functional integrity to the bone but not CSDs. A 
collaborative effort between the Mechanical Engineering, Regenerative Biology and Food Science & 
Human Nutrition Departments at the University of Illinois, Urbana-Champaign has yielded the following 
study of long bone regeneration in the Xenopus Laevis. A recent 6-month study performed by Dr. Liang 
Feng et al. (MechSE, UIUC) has shown promise in long bone regeneration capabilities in CSDs of the 
Xenopus Laevis using scaffolds loaded with growth factors [5]. This study is an extension of his work. 
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1.3 The Animal Model: Xenopus Laevis 
 
 
The Xenopus Laevis, commonly known as the African clawed frog, is a species of South African 
aquatic frog which can grow up to 12 cm and have a flattened head or body but no tongue or external 
ears. Similar to mammals, adult Xenopus Laevis frogs fail to regenerate bone over critical size defects. 
The Xenopus Laevis frogs also repair fractures similar to the mammalian bone regeneration and 
remodeling processes. Therefore, they serve as viable animal species to study long bone regeneration. 
Other advantages to using the Xenopus Laevis model include easy surgeries, non-cumbersome post-
operative care, and relatively inexpensive use and maintenance. No external stabilization is required after 
bone removal for these animals. The tarsus bone beds of the Xenopus Laevis are used in this research 
study to investigate long bone regeneration. The critical size defect of the Xenopus Laevis long bone is 
known to be approximately 35% of the length of the long bone which is significantly larger than 
mammalian species [5]. 
 
Figure 2 (left): The adult Xenopus Laevis frog used in long bone 
regeneration studies [5]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 (top-right): Schematic drawing showing the bone structure of Xenopus hind limb and area of 
tarsus removal for our studies [5]. 
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1.4 Preliminary Data 
 
 
Dr. Liang Feng’s study included testing bone regeneration using HDDA scaffolds loaded with 
growth factors, Bone Morphogenetic Protein 4 (BMP4) and Vascular Endothelial Growth Factor (VEGF) 
implanted in critical size defects in the Xenopus Laevis at long-term time points of 3 months and 6 
months [5]. This study yielded promising results which are shown in Figures 4 and 5.  
 
 
 
 
 
 
 
 
A) W/o scaffold       B) W/o scaffold    C) W/o scaffold     D) With Scaffold+BMP4+VEGF 
 
Figure 4:  Preliminary determination of the critical size defect for Xenopus tarsus bone.  Tarsus 
extirpations removing bone segments of different lengths were performed, and frogs were allowed to heal 
for 3 months post-surgery.  Significant re-ossification of the gap (arrow) is observed after removal of a 
2.5 mm segment (approximately 23% of the length of the bone) in (A), while larger extirpations of 4 mm 
(approximately 37% of length of the bone) (B) and 6.5 mm (approximately 59% of length of bone) (C) 
show little apparent ossification. (D)  A 5 mm gap (approximately 45% of length of the bone) was 
implanted with a scaffold soaked in growth factors BMP4 and VEGF.  3 months after surgery, significant 
ossification has taken place in parts of the gap (arrows) [5]. 
 
 
It has been concluded from the above data that in non-critical size defects (i.e. a defect of <35% 
of the length of the bone in the Xenopus Laevis), natural healing without the aid of biomaterial 
implantation was observed. However, in a critical size defect of greater than 35% without biomaterial 
implantation, the frogs were unable to bridge the gap with neither bone nor cartilage. Furthermore, a 
critical size defect that has an implanted polymer scaffold loaded with BMP4 and VEGF, promoted 
cartilage growth and initial ossification.  
 
 Additional studies showed that
enabled by a scaffold containing growth factors and allowed to heal for a long period of time, such as 6 
months. Significant ossification and complete
histology showed that premature bone was slowly starting to ossify into secondary or lamellar bone. 
 
 
    A   
 
 
 
 
1.5 Objectives 
 
 
The objectives of this particular study are mainly to characterize
growth factor- assisted long bone regeneration in CSDs
term objectives of this study are to promote long bone regeneration with the use of scaffolds loaded with 
growth factors to stimulate developmental regeneration, to design and fabricate scaffolds with optimum 
architecture for transport, and to develop a predictive, experimentally
bone tissue.  
 
In-vivo experiments focus on the following 
1. Use of novel biocompatible scaffolds
(BMP4, VEGF, FGF10) that promote 
defect space. 
6 
 complete ossification in critical size defects was possible if 
 bridging of the critical size defect was observed and 
Figure 5 (left): [A] Critical size defect 
in the tarsus of the 
which has been left to regenerate for 3 
months. No regeneration observed.
[B] CSD with scaffold and growth 
factor implantation after 3 months. 
Initial ossification observed. [C] CSD 
with scaffold and growth factor 
implantation after 6 months. Complete 
bridging of gap and significant 
ossification observed [5].
B           C 
 fractures and scaffold
 during the early stages of regeneration
-based modeling tool for growth of 
areas: 
 (HDDA and zein) that contain and release biological factors
de novo cartilage-to-bone development within the critical bone 
 
Xenopus Laevis 
 
 
- and 
. The long-
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2. Implantation of HDDA and zein scaffolds into hemi-extirpated tarsus bone beds.  Characterization of 
the progress of de novo cartilage-to-bone repair from the initial stages of repair up to 6 weeks. 
3. Induction of fractures in the tarsus bone beds. Characterization of the progress of bone growth and 
remodeling during fracture stages up to 3 weeks. 
 
 
1.6 Motivation  
 
 
The initiation, progression and conclusion of ossification in a CSD using fractures and 
developmental growth as models are not very well understood. With 250,000 surgeries per year involving 
bone grafts in the US alone, the demand for materials and proper bioengineering is essential [6, 7, 8]. 
Medical costs of tissue damage due to deficient regeneration or non-regeneration are enormous ($400 
billion/year in the United States alone) [7]. Additionally, dysfunction, inability to move a limb, weakened 
quality of life and early death are several of many causes for a need to drive research in this field. 
Orthopedic applications will greatly improve with novel understanding and design of optimum biological 
scaffolds for regeneration. Subsequently, these technologies can be encapsulated into mathematical 
models to quantify and predict future problems with regeneration and also provide a deeper understanding 
of the phenomena occurring during the mechanisms of regeneration. These approaches are steps that are 
essential for performing interdisciplinary research by using bioengineering to create materials tailored to 
regeneration processes and systems biology to jumpstart a phenomenon that is otherwise naturally 
impossible. This research will not only contribute to the field of tissue engineering, but will also 
contribute to the fields of manufacturing (fabrication of novel scaffold materials), materials science 
(biocompatibility and bioacceptance of various materials) and multi-scale biology-based materials 
modeling where experimental data will serve as inputs for modeling.   
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1.7 Applied Techniques to Promote Long Bone Regeneration 
 
 
1.7.1 Enhanced Bone Healing: Grafting 
 
 
Following fractures or fairly large defects, various techniques have been used by physicians for 
years in order to heal bone tissue. For fractures, the most common technique is immobilization where the 
two ends of the broken bone are stabilized and aligned by inserting surgical nails, screws, plates, rods or 
wires to ensure proper fracture healing. For example, in a tibial fracture, the most commonly used 
procedure is Intramedullary Rodding whereby a metal rod is placed down the center of the tibia through 
the medullary cavity to stabilize the alignment of the bone. The rod is secured with screws both above and 
below the fracture. The metal screws and rod may be left in the bone for life or removed if they cause 
complications such as infections or movement. External immobilization may also be achieved by plaster 
or paris or fiberglass casts and slings [9].  
 
Most often, for large defects, invasive intervention is essential to accelerate the healing of bone 
tissue. Most commonly used techniques for accelerating bone healing involve various types of grafting. 
The gold standard for grafting bone tissue is the cancellous autologous bone graft. It is extensively used in 
orthopedic procedures since it provides few living osteoblasts, growth factors and hydroxyapatite mineral 
taken from one part of the host body and implanted into the defect site in the same body. The advantage 
to autologous grafts includes a reduced immune response; however, potential disadvantages include donor 
site morbidity and scarring [10].  
 
Another common source of bone graft is the use of allograft bone. An allograft bone graft is bone 
harvested from cadavers or deceased individuals who have donated their bone for use in the treatment of 
living patients. This is commonly used in many forms for spinal fusions ranging from cervical interbody 
fusions to lumbar interbody fusions and provides excellent structural support. However, studies have 
shown that risk rate and failure rate is high amongst allograft bone recipients due to an immense immune 
response, infections and its biological inadequacies as a stimulant to unite certain bones [11].   
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Xenografts, tissues implanted into a human recipient from a non-human source, have been 
controversially used as a grafting technique for bone tissue. Although xenograft availability and use in 
orthopedic procedures have increased dramatically, useful results are scarce. A relative shortage of 
allograft tissue accounts for virtually an infinite amount of xenograft tissue that is available. This 
availability has been the framework for the rapidly developing xenograft market. Cross-species tissue 
transplantation presents challenges that are more difficult to overcome as compared to traditional 
transplantation. The risks of infection include zoonoses, or infectious diseases that may be passed across 
species from animals to humans [12]. 
 
Another novel technique being investigated called Demineralized Bone Matrix (DBM) allows for 
some risk control over allografts and xenografts. Important bone forming proteins are extracted from 
demineralized allograft bone, resulting in a paste-like matrix that may be implanted in the defect site for 
bone tissue healing. Although it has successfully fused spines in animal studies, there is no evidence that 
this is a powerful enough stimulus to successfully unite a human spine and is therefore not recommended 
for use without the aid of the patient's own bone. It is only recommended as a bone graft extender and not 
a replacement [11]. 
 
 
1.7.2 Enhanced Bone Healing: Research 
 
 
There are three commonly observed bone growth mechanisms: osteoconduction, osteoinduction 
and osseointegration. Most bone research involves investigating at least one of these three mechanisms. 
Osteoconduction is a process where bone grows on some surface. This phenomenon occurs on implants 
where bone is known to not to be osteoconductive on materials such as copper, silver or bone cement. 
Osteoinduction is the process by which osteogenesis or bone formation is induced. Osteoinduction 
involves the recruitment of immature cells to develop them into preosteoblasts. For example, fracture 
healing is dependent of osteoinduction. Osseointegration is the docking of an orthopedic implant by direct 
10 
 
bone-to-implant contact. Bone in-growth into a porous scaffold provides osseointegration. It is important 
to assess all three of these mechanisms while conducting bone tissue healing research [13]. 
 
Traditional tissue engineering investigations of any tissue regeneration in the human body may 
include one or more of three components: soluble factors such as growth factors, scaffolds and cells. In 
orthopedic research, many of the bone regeneration investigations have led to relatively fair bone 
formation, yet none so far have yielded mature, physiologically and structurally intact, and functional 
bone tissue which is identical biologically and mechanistically to original bone. Therefore, it is important 
to piece together this puzzle by assessing all the different techniques, materials and information available 
and incorporating the best of these approaches by taking into account their advantages and disadvantages 
in orthopedic research. 
 
1.7.3 The Use of Growth Factors in Fractures and CSDs 
 
 
Many growth factors are now known today to promote bone growth and are being extensively 
used in bone regeneration applications. Early studies have shown that BMPs formed bone at ectopic sites 
independent of endochondral ossification; this opened doors to direct osteoinduction using BMPs by 
intramembranous ossification [14]. Osteoinduction in rats by activation of the BMP-2 human gene using 
in vivo transcutaneous electroporation has shown bone formation at ectopic sites as well. Kawai et al. 
have successfully transferred the human BMP-2 gene and observed well-mineralized trabecular bone and 
mature bone marrow with the presence of activated osteoblasts and osteoclasts in target muscle cells in 
rats. This shows that it is indeed possible to induce bone growth simply by activating a single gene 
expression of a common bone growth factor, BMP-2, where bone normally does not grow [15].   
 
It has been observed that growth factors such as BMPs and a myriad of others play a critical role 
in regulating cellular processes while regenerating bone. Ribonuclease Protection Assays performed by 
Gerstenfeld et al. investigated the presence and possible role of about 50 growth factors, most importantly 
TGFs, ILs, BMPs, VEGF, etc. by characterizing their temporal mRNA expression patterns over time 
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during natural fracture healing. Many of the growth factors appear to have overlapping functions at 
various stages, making it difficult to identify the specific role of a single growth factor or a combination 
of a few growth factors at each stage of fracture healing [16]. BMPs are suggested to act locally both to 
recruit stem cells and to induce them to differentiate into bone-forming cells such as osteoblasts. The 
ability of BMPs to stimulate osteogenesis has been demonstrated in numerous studies by Guldberg et al. 
[17].  
 
The delivery sequence of growth factors is also important since inappropriate growth factor 
delivery sequences or combinations may stimulate signaling cascades that lead to bone resorption or other 
undesirable outcomes [18]. Jeon et al. investigated in vivo delivery of BMP-2 at varying time scales in 
fracture repair, obtaining the result that long-term delivery (sustained release for about 4 weeks) of BMP-
2 leads to significantly greater bone formation than short-term delivery (about 3 days) [19].  
 
 
 
 
 
 
 
 
 
Figure 6 (left): Temporal mRNA 
expression patterns during natural 
fracture healing. Bar thickness 
represents relative intensity of 
expression [16]. 
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Figure 7: Genes expressing various growth factors during the 4 stages of fracture repair [10]. 
 
 
Although the use of osteoinductive growth factors for bone healing has provided ample evidence 
of their importance, research has been hindered by the selection of optimal carrier and dosage. Today, we 
have a wide range of information regarding many growth factors, their spatial and temporal gene 
expressions, and their functions [10]. It is therefore useful to mimic the cellular behavior in fracture 
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healing to regenerate bone in CSDs; however, it is impossible to use all of the growth factors described 
above in one system.  
 
In CSD bone regeneration, Mayr-Wohlfart et al. report that VEGF induces migration of 
osteoblasts, which would be possible only in bone repair strategies that involve VEGF delivery [20]. 
Huang et al. suggest that BMP-4 plays a role as an osteoinductive signal that promotes recruitment of 
surrounding repair cells to enhance bone regeneration [21]. Whether VEGF or BMP is involved, the 
phenomenon is similar: cell migration is vital in a CSD bone regeneration process in order to bridge the 
large gap between the two ends of the bone. Cells need to move up a concentration gradient of a 
substance, such as a chemical factor in order to start rebuilding bone. 
 
Another type of activity that is involved in bone repair is the synergistic response of cells to more 
than one growth factor in CSDs. BMP-4 and VEGF work synergistically in driving osteoprogenitor cells 
to differentiate into osteoblasts. Peng et al. report an ideal BMP-4 to VEGF ratio for bone formation [22]. 
Similarly, a histomorphometric analysis by Simmons et al. shows that the delivery of both BMP-2 and 
TGF-B3 has a significantly greater effect on bone formation than the delivery of just one of the growth 
factors [23]. Raiche et al. describe the dual effect theory, which proposes that priming stem cells with 
BMP-2 prior to adding Insulin-like Growth Factor I (IGF-I) stimulates greater cell proliferation in CSDs 
[23].  
 
1.7.4 The Use of Scaffolds in Fractures and CSDs 
 
 
Thus far, a common delivery mechanism of the above-mentioned growth factors has been through 
the use of scaffolds or natural and synthetic grafts. Many growth factors such as TGF-β1, FGFs, and 
rhBMP2 have been carried and delivered in bone tissues in various animal models to successfully 
regenerate some bone tissue in several different bones (skull, long bones, vertebrae, maxilla, etc.) during 
fracture repair. Some of these include collagen, collagen-GAG absorbable scaffolds while others are non-
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absorbable such as bioactive glass. Many of the scaffolds used are synthetic, the most common one being 
PLA or PLGA [10].  
 
Barrère et al. have investigated the properties and clinical applications of a variety of synthetic 
and natural biomaterials that have been used as scaffolds for musculoskeletal repair. Metals such as 
titanium and aluminum have shown to provide much of the mechanical strength of bone; however, they 
have limited degradation and bioactivity. Thus, in many cases, they are used as long-term implants rather 
than growth factor delivery carriers. Other synthetic scaffolds such as polymers (PEG, PLA, PGA, 
PLGA) have been extensively used as growth factor delivery vehicles since they have controlled 
degradation and soluble factor release characteristics as well as controlled porosity for cellular migration 
[24].   
 
In irradiated osseous defects, VEGF scaffolds have shown the ability to enhance 
neovascularization and bone regeneration, outlining a novel approach for engineering tissues in 
hypovascular environments. For patients suffering from bone cancer who have had to undergo extensive 
chemotherapy, this may be an optimal solution to regenerate lost bone [25].  
 
Most scaffold technologies used have been for osteoconductive purposes. An osteoconductive 
material is known to guide repair in a location where normal healing would not occur if left untreated. 
Polymers can differ in their molecular weight, polydispersity, crystallinity, and thermal transitions. The 
relative hydrophobicity and percent crystallinity can affect cellular phenotype. Variation in the pore size 
of the scaffold can have a profound effect on the attachment and long term survival of cells since a 
specific cell type has optimal pore topography and size [26]. It has been reported that in the human body, 
the distance between blood vessels and mesenchymal stem cells are no larger than 100 µm [27]. However, 
pores must be large enough to guide cell migration. Therefore, pore size, relative density and cell 
migration play principle roles in the design of scaffolds. 
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CSD healing was also tested with polymeric scaffolds loaded with doses of co-delivered BMP-2 
and TGF-β3. However, the growth factor augmented constructs failed to consistently produce bone union 
across the defect and did not significantly improve torsional strength relative to scaffold-only groups. 
Although this low dose has been shown to induce osteogenesis in an ectopic model, this study performed 
by Oest et al. suggests that a higher dose of BMP-2 and TGF-β3, or some other combination of growth 
factors, is required to restore function to large orthotopic defects [28]. Hence, this study suggests that 
scaffolds with growth factors provide a better biological environment for osteogenesis as compared to 
scaffolds alone that have been implanted.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: 2-D X-rays of rat hind limbs at 0, 8 and 16 weeks post-op showing empty critical size defects, 
defects with PLDL scaffolds, and defects with PLDL scaffolds loaded with BMP-2 and TGF-β3 [28]. 
 
 
16 
 
Other studies involved not only using scaffolds as growth factor gene expression delivery 
mechanism but also as a bed for seeded cells.  Huang et al., delivered BMP-4 plasmid DNA and human 
bone marrow stromal cells (hBMSCs) using interconnected, 91% porous PLGA scaffolds.  BMP4 is 
secreted by both the seeded hBMSCs and the surrounding host cells to form mineralized, bone tissue that 
resembled immature, woven bone after 15 weeks [21]. Therefore, scaffolds have not only been used as 
delivery carriers for growth factors or gene expression for growth factors, but also as cell-seeded beds to 
recruit local host cells in the regeneration process.  
 
1.7.5 Cellular Activity in Fractures and CSDs 
 
 
Immediately following bone injury, blood vessel disruption leads to the development of a blood 
clot that fills the defect site with a fibrin-rich extracellular matrix. Accumulating platelets and the 
immigrating neutrophils and macrophages provide a source of growth factors such as platelet-derived 
growth factor (PDGF), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) 
and a broad spectrum of other bioactive molecules that target mesenchymal progenitor cells with their 
osteochondrogenic potential. Blood capillaries sprout into the blood clot by a process called angiogenesis 
[29].  
 
In parallel, endothelial progenitor cells that originate from the bone marrow are transported via 
the blood stream to the site of blood vessel formation where they contribute to capillary sprouting. This 
process is termed vasculogenesis [30]. Once the blood clot is replaced by the blood vessel-rich 
granulation tissue, differentiation of mesenchymal progenitor cells into functional osteoblasts is initiated. 
Low oxygen tension and the instability of a fracture, however, favor the differentiation of mesenchymal 
progenitor cells into the chondrogenic lineage. Cartilaginous tissue, which stabilizes the defect site, is 
then replaced by bone via endochondral ossification. Lamellar bone is laid appositionally onto immature 
woven- and pre-existing bone, as well as onto osteoconductive surfaces of implants and grafting materials 
[16, 31]. 
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Very few sources carry information regarding cellular activity in CSDs and bone regeneration. 
This is partly because whole bone regeneration has been minimally achieved in most cases and 
histomorphometric analyses have not been conducted to assess the cellular processes within CSDs that are 
essential to bone regeneration. Bone development, remodeling and regeneration fundamentally depend on 
the same elements: mesenchymal progenitor cells that differentiate into osteoblasts or chondrocytes, 
haematopoietic progenitors that give rise to osteoclasts, local clues that attract the cells and control their 
proliferation and differentiation into the mature phenotypes, and a provisional matrix, which defines the 
area for these dynamic processes [32]. 
 
1.8 Summary 
 
  
 Although bone grafting is one of the most commonly used methods for healing a large bone 
defect, donor-site morbidity, a large immune response, and infections are a few disadvantages. Since 
ample information about fracture healing is already available in literature and applied techniques, similar 
processes can be used to design experiments to investigate CSDs. Recent research involving cells, 
scaffolds and growth factors as presented above has shown promise in treating critical size bone defects.  
Since our research focuses on the Xenopus Laevis animal model, it is not viable to use cells in this 
investigation since obtaining Xenopus Laevis mesenchymal stem cells (the primary progenitor cell type 
required for bone formation) is a challenge in itself. However, the use of growth factors and scaffolds is 
definitely feasible and therefore is the approach taken here to study CSDs. 
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Chapter 2: Materials and Methods 
 
 
 
2.1 Scaffold Fabrication 
 
 
 2.1.1 HDDA Scaffolds 
 
 
Projection Micro Stereo Lithography (PµSL) is a novel three dimensional fabrication technology 
that was used to construct 1,6 hexanedioldiacrylate (HDDA) (Sartomer Company, Inc, Exton, PA) 
scaffolds that were used in this study. The HDDA scaffolds were made as hollow cylinders to match the 
dimensions of the excised frog tarsus in the central diaphyseal region which are 1.2 mm outer diameter 
and a 0.8 mm inner diameter and 10 mm in length. PµSL generates 3D structures using Computer Aided 
Design (CAD) software, which it uses to slice the structure into a sequence of bitmap images according to 
the desired spatial resolution on the direction perpendicular to the slicing planes with each image 
representing a thin layer of microstructure. A single image is displayed on the micro display chip during 
each fabrication cycle. A reduction lens is then used to capture the image and the reduced image is then 
focused onto a photo curable liquid surface. A 2-20 µm thick layer is cross-linked and polymerized 
simultaneously under exposure to the photo curable liquid surface. After one layer is solidified, a new 
fabrication cycle starts when the polymerized part is immersed into the liquid surface to allow a new thin 
liquid layer to form on top. A 3D microstructure is formed from a stack of layers by repeating the cycle 
described above [5, 33]. The fully-constructed HDDA scaffolds were then stored in ethanol for 1 day to 
ensure sterility and then rinsed and soaked in sterile PBS for at least 48 hrs. The scaffolds were cut during 
surgeries to match the exact removed bone section from the CSD in one of the two tarsal bones of adult 
Xenopus laevis left hind limbs. The scaffolds were soaked in growth factor solution with a combination of 
BMP4 and VEGF for 2 hours prior to surgical implantation in the CSD in the frog limbs [5]. 
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Figure 9: SEM images of porous, hollow HDDA scaffold, 127X45 mm 
Scale bar on the left is 500 µm and scale bar on right is 200 µm [5]. 
 
 
 
 2.1.2 Zein Scaffolds 
 
 
The zein scaffolds were fabricated using a different chemical method. Each scaffold was made 
with 3 grams of stearic acid mixed with 22.5 ml 70% ethanol. The mixture was heated until stearic acid 
dissolved well in ethanol and the mixture reached 120 degrees to 140 degrees F. Three grams of yellow 
zein, obtained from Showa Sanyo (Tokyo, Japan) was added to the mixture and was heated for another 10 
minutes until the temperature reached 140 degrees to 160 degrees F. The zein was then taken out of the 
heater and added to cold water. Since zein is a hydrophobic protein, it aggregates together to form a gel. 
During the solidification of the zein gel, it was removed from the cold water and shaped into a rod using a 
needle as a core. The scaffold was then allowed to dry at room temperature and the needle was removed 
[34]. This scaffold resembled a very small piece of pasta, with minimal porosity and high zein density. 
The zein scaffolds were also cut to match a surgically created CSD in the one tarsus bone of adult 
Xenopus laevis left hind limbs. The scaffolds were rinsed and soaked in sterile PBS for at least 48 hrs 
prior to coating with growth factors and surgical implantation and were soaked in growth factor (BMP4 
and FGF10) solution for two hours prior to surgical implantation. 
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Figure 10: SEM images of slightly porous zein scaffolds [A] at 50 µm resolution, and [B] at 1 mm 
resolution of a 4 X 1.5 mm zein scaffold with a hollow core oriented horizontally, and [C] at 1 mm 
resolution of the same scaffold with the hollow core oriented vertically [34]. 
 
 
 
2.2  In-Vivo Experiments 
 
  
Sexually mature Xenopus Laevis frogs were obtained from Xenopus Express, Inc (Brooksville, 
FL). The frogs were allowed to acclimate to lab conditions for one week prior to surgery. All surgeries 
and animal care were performed in accordance with the University of Illinois at Urbana-Champaign 
Institutional Animal Care and Committee (UIUC IACUC) procedures. Animals were divided into three 
groups for histology: CSD control group (n=11), CSD scaffold + growth factors group (n=21) and 
fracture group (n=7). In total, 39 frogs were used for the following experiments. The frogs were 
anesthetized in an osmotically-balanced dechlorinated water, containing 0.15% ethyl 3-aminobenzoate 
methane sulfonate salt (MS222, Sigma), a standard amphibian anesthetic. Frogs were left in the 
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anesthesia until no response was seen when pinching their thighs with forceps or when turned over onto 
their backs. 
 
To create a CSD for the control group, the central (diaphyseal) segments of posterior tarsus bone 
of left hind limbs were cut using surgical scissors, ranging from 4.5 to 7 mm in length (the length of 
tarsus is approximately 12 mm on average). The anterior tarsus bone was left intact to maintain structural 
support. This process also damaged lateral diaphyseal skeletal muscles, the interosseous ligament and 
surrounding nerve tissue and blood vessels. The wounds were then closed with 6-0 Ethilon 0.7 metric 
sutures from Ethicon. 
 
For the CSD with scaffold + growth factor group, the cut segmental pieces in the CSD were 
measured. The scaffolds were trimmed to match the length of the excised CSD. The HDDA scaffolds had 
been soaked for 2 hours in a growth factor solution containing Bone Morphogenic Protein 4 (BMP4) and 
Vascular Endothelial Growth Factor (VEGF) (Sigma) at concentrations of (1 mg/ml BMP4 + 50 mg/ml 
VEGF in 4 mM HCl with 0.1% BSA) prior to implantation. The zein scaffolds had been soaked for 2 
hours in a growth factor solution containing Bone Morphogenic Protein 4 (BMP4) and Fibroblast Growth 
Factor (FGF10) (Sigma) at concentrations of 1 mg/ml BMP4 + 50 mg/ml FGF10 in 4mM HCl with 0.1% 
BSA prior to implantation. After scaffolds were placed in the defect space, the wounds were closed with 
the above-mentioned sutures. 
 
For the fracture group, the central (diaphyseal) segments of posterior tarsus bone of left hind 
limbs were cut with surgical scissors to create a break in the continuity of the bone. The frogs were left to 
heal naturally with no biomaterial implantation. All frogs were then placed in osmotically-balanced 
Holtfreter’s solution in dechlorinated water to recover from the anesthesia. Frogs were closely observed 
throughout the wound healing and regeneration process.  
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2.3 Sample Collection 
 
 
 3 days 1 week 2 weeks 3 weeks 6 weeks 
CSD control 1 sample 2 samples 4 samples 4 samples  
CSD + HDDA scaffold + 
VEGF + BMP4 
1 sample 4 samples 4 samples 4 samples  
CSD + zein scaffold + 
FGF10 + BMP4 
  4 samples  4 samples 
Fracture 1 sample 2 samples 2 samples 2 samples  
 
Table 1: Number of samples categorized into each group showing the collection time points for histology. 
 
 
Samples from each group as shown above were collected at the following time steps: 3 days, 1 
week, 2 weeks and 3 weeks after surgery as shown in Table 1 for histology. 13 samples that were in the 
CSD with scaffold + growth factor group were implanted with HDDA scaffolds. The remaining 8 
samples from the CSD with scaffold + growth factor group were collected at 2 weeks and 6 weeks and 
were implanted with zein scaffolds. After frog euthanization by over-anesthetization with a 0.3% MS222 
solution in osmotically-balanced dechlorinated water, the tarsus limb segments were collected by cutting 
just distal to the tarsal-metatarsal joint and just proximal to the ankle joint using a razor blade. The tarsus 
samples for histology were rinsed for 10 minutes in sterile 1xPBS in three subsequent washes, and then 
fixed in 0.4% paraformaldehyde in 1X PBS overnight. 
 
 
2.4 Micro-CT Imaging 
 
 
Following fixation, the collected Xenopus scaffold + growth factor tarsus samples were put into 
eppendorf tubes and scanned with a Sky Scan 1172 MicroCT (SkyScan, Kontich, Belgium) at the 31.6 
µm voxel resolution to check for structural changes as well as new tissue formation. Amira 4.0 software 
was used to reconstruct the imaged data into a 3D visualization. The thresholds were selected in each 
sample to focus more on the bony tissue and exclude the scaffold and soft tissue. The defect percentages 
were calculated as the ratios of the defect size to the whole tarsus size. 
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2.5 Sample Analysis 
 
 
All histology samples were decalcified in Calci-Clear Rapid (National Diagnostics, Atlanta, GA) 
solution for 8 hrs, washed with 1X PBS, then cryoprotected for 24 hours each in sterile 10%, 20%, 30% 
sucrose in 1X PBS. Samples were then embedded with a 50:50 solution of 30% sucrose in 1X PBS and 
Neg 50 frozen section medium (Richard-Allan Scientific), and frozen in isopentane cooled by liquid 
nitrogen. The cryogenized blocks were sliced into 20-30 µm sections using a Leica CM 1900 cryostat and 
stained with hematoxylin and eosin. The stained histology slides were then imaged at 460 nm resolution 
using the NanoZoomer Digital Pathology System (Hamamatsu).  
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Chapter 3: Results 
 
3.1 The Xenopus Laevis  Limb 
 
The Xenopus Laevis frog limb that is being investigated consists of two tarsal bones similar to the 
radius and ulna in humans. They are approximately 11 to 12 mm in length and 0.5 mm in central 
diaphyseal diameter. The induced critical size defects are approximately 4.5 to 7 mm in length cut from 
the central diaphyseal region. This accounts for approximately 37.5% or more of the length of the bone 
which the adult amphibian is not able to bridge by healing naturally. The two tarsal bones are connected 
in the middle through the interosseous ligament. Adjacent to the interosseous ligament are the 
interosseous artery and interosseous nerve, two anatomical structures important for regeneration and 
remodeling of bone. Surrounding the two tarsus bones are skeletal muscles which attach to the inner layer 
of skin in the limb. The skin is very loosely attached and cuts away easily during surgery. Shown below 
are the Micro-CT image of an intact, unoperated tarsus limb and a schematic of the anatomical structures 
of the generic frog limb.  
 
 
 
 
 
 
 
Figure 11: A schematic showing the anatomical structures in a cross-section within a frog limb. 
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Figure 12: An Amira reconstructed Micro-CT image, scanned at a 31.6 µm resolution, of an intact tarsus 
limb showing the two tarsal bones with length of 11.2 mm and a central diaphyseal diameter of 0.53 mm.  
 
3.2  Long Bone Regeneration at 3 days 
3.2.1 CSD at 3 days 
Sample Frog 1  
Critical Size Defect 49%  
Proximal cut-site Blood and immune cells present 
Center of Defect Damaged muscle, interosseous ligament and blood vessels 
Distal cut-site Blood and immune cells present 
 
Table 2: Summary of tissue activity in the CSD at 3 days post-surgery. 
One frog was chosen to study CSD at day 3 post-surgery. Three days after a critical size defect 
was induced in the tarsus of a Xenopus Laevis hind limb, the limb produced a large blood clot, which has 
been encapsulated by fibrous tissue. Since the blood vessels were severely damaged in the defect, the 
blood is highly present at the cut-sites as compared to the center of the defect. The induced defect not 
only removed bone, but significantly damaged surrounding muscles, blood vessels, nerves and the 
interosseous ligament connecting the two tarsal bones.  
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         A: proximal cut-site 
 
 
 
         B: center of defect 
 
 
 
 C: distal cut-site 
 
 
 
 
 
 
 
 
 
 
Figure 13: Schematic representation of the tarsal bone system with an induced critical size defect 3 days 
post-surgery. Red dashed lines indicate the approximate plane of displayed histological cross-sections. 
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       Frog 1: Section A              Frog 1: Section B 
 
     A              B 
 
 
 
 
 
 
  Frog 1: Section C          Frog 1: Section B (high mag) 
 
       C      D 
 
 
 
 
 
 
 
Figure 14: [A] Low magnification image of the cut-site at the proximal end of the operated tarsal bone 3 
days after the induced CSD. Cut-site is surrounded by blood and immune cells (red arrow). Interosseous 
ligament is still fairly intact at this stage. [B] Low magnification image of a section in the center of the 
defect. Large amounts of fibrous, scar tissue can be seen. [C] Low magnification image of the distal cut-
site surrounded by blood and immune cells (red arrow) [D] High magnification (5X) of image [B] 
showing torn interosseous ligament (green arrow), bone defect (yellow arrow) and dying muscle cells (red 
arrow). Black scale bars represent 1 mm. 
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3.2.2 CSD at 3 Days with HDDA Scaffold and Growth Factors (BMP4 
AND VEGF) 
 
Sample Frog 1  
Critical Size Defect 51% 
Proximal cut-site Large amount of blood, few immune cells present 
Center of Defect Large amount of blood present around and inside scaffold, few 
immune cells present 
Distal cut-site Large amount of blood, few immune cells present 
 
Table 3: Summary of tissue activity in the CSD with implanted scaffold loaded with growth factors, 
BMP4 and VEGF at 3 days post-surgery. 
 
 
One frog was chosen to study CSD implanted with the HDDA scaffold loaded with growth 
factors BMP4 and VEGF. In the critical size defect, an HDDA scaffold loaded with growth factors BMP4 
and VEGF was placed and histological sections were analyzed. There was also significant amount of 
damage to the interosseous ligament and surrounding skeletal muscle. Even though a large amount of 
blood was observed at the cut-site around the implanted scaffold, a decreased number in immune cells 
shows that this scaffold is fairly biocompatible and moderately immuno-resistant. Within the hollow core 
of the scaffold, a large amount of blood is present and fibers are starting to form showing some cellular 
activity as opposed to scar tissue formation and in-growth as seen in the untreated critical size defect. 
 
         A: proximal cut-site 
          
         B: center of defect  
          
 
 C: distal cut-site   
 
 
Figure 15: Schematic representation of the tarsal bone system with an induced critical size defect 
implanted with an HDDA scaffold loaded with growth factors BMP4 and VEGF 3 days post-surgery. Red 
dashed lines indicate the approximate plane of displayed histological cross-sections. 
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  Frog 1: Section A    Frog 1: Section B 
 
          A       B 
 
 
 
 
 
 
  Frog 1: Section C     
          C  
                 D    
        
 
 
 
 
       Frog 1: Section B (high mag) 
Figure 16: Images of cross-sections taken at the proximal cut-site of a frog after 3 days of implantation of 
the HDDA scaffold loaded with growth factors BMP4 and VEGF. [A] Low magnification image of the 
proximal cut-site surrounded by blood and immune cells. [B] Low magnification image of the center of 
the defect showing scaffold surrounded by a large amount of blood and very few immune cells. [C] Low 
magnification image of the distal cut-site surrounded by blood. [D] High magnification image (5X) of [B] 
displaying the intensity of blood (red arrow) surrounding the HDDA implanted scaffold and surrounding 
dying muscle cells (green arrow). Blood and cellular activity are also present inside the hollow core of the 
HDDA scaffold (yellow arrow). Black scale bars represent 1 mm in [A], [B], and [C] and 500 µm in [D]. 
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3.2.3 Fracture at 3 Days  
 
One frog was chosen to study fracture at day 3 post-surgery. After 3 days, a fracture hematoma is 
not yet observed but blood and cellular debris are being cleared by phagocytes and other immune cells. 
Ruptured blood vessels are trying to reorganize. Swelling of the tissue and the limb itself is observed.  
The surrounding muscle cells are starting to die and very few of them are still attached to the bone site. At 
the fracture site, cells from the bone marrow are starting to migrate outward into the defect space.  
 
 
 
 
        
         A: proximal to fracture site 
 
          
B: fracture site 
 
 
 
 
 
Figure 17: Schematic representation of the tarsal bone system with an induced fracture after 3 days. Red 
dashed lines indicate the approximate plane of displayed histological sections. 
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  Frog 1: Section A    Frog 1: Section A (high mag) 
 A             B 
 
 
 
 
 
 
 
 
  Frog 1: Section B 
 
C 
 
 
 
 
 
 
 
 
 
Figure 18: Images of cross-sections taken at the fracture site of a frog after 3 days of fracture healing.  
[A] Low magnification image showing cross-section very close to fracture site. [B] High magnification 
image (5X) of [A] displaying the intensity of blood (red arrow) and exuding marrow material surrounding 
the fracture site and surrounding dying muscle cells (green arrow). [C] Low magnification image of 
fracture site showing defect space surrounded by blood and dying muscle cells. Black scale bars represent 
1 mm. 
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3.3 Long Bone Regeneration at 1 Week 
 
3.3.1 CSD at 1 Week 
 
 
Sample Frog 1 Frog 2 
Critical Size Defect 52% 54% 
Proximal cut-site No blood present, few immune 
cells present 
Large amount of blood present, 
few immune cells present 
Center of Defect Fair amount of blood present, 
initial formation of scar tissue, 
dying muscle cells 
Large amount of blood present, 
initial formation of scar tissue, 
dying muscle cells 
Distal cut-site No blood present, few immune 
cells present 
Small amount of blood present, 
few immune cells present 
 
Table 4: Summary of tissue activity in the CSD at 1 week post-surgery. 
 
Two frogs were chosen to study CSD at 1 week post-surgery. After 1 week, there is not a 
significant regeneration response in tissue formation in the critical size defect. Critical size defects were 
induced in 2 frogs to observe their regenerative responses. The immune response has decreased in both 
frogs with only residual amounts of immune cells present but a fair amount of blood is still present in 
Frog 1 and a large amount of blood is still present in Frog 2 in the center of the defect. At this time, a 
large amount of dying muscle tissue is observed surrounding the defect space in both frogs which is 
slowly being invaded by scar or fibrotic tissue. There is no indication of a hematoma or even granulation 
tissue that maybe observed in fracture healing at this stage. Cartilage is not present and the interosseous 
ligament does not seem to be reforming or reattaching since there is missing osseous tissue in both frog 
limbs.  
   A: proximal cut-site 
          
   B: center of defect  
 
         
      
 
Figure 19: Schematic representation of the tarsal bone system with an induced critical size defect after 1 
week. Red dashed lines indicate the approximate plane of displayed histological sections. 
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   Frog 1: Section A          Frog 2: Section A 
    A            B 
 
 
 
 
 
 
   
Frog 1: Section B    Frog 2: Section B 
    C           D 
 
 
 
 
 
 
   E             F  
 
 
 
 
 
 
  Frog 1: Section B (high mag)   Frog 2: Section B (high mag) 
Figure 20: Images of cross-sections taken at the critical size defect sites of 2 frogs after 1 week of healing. 
[A] Low magnification image showing cross-section at the proximal cut-site of Frog 1. [B] Low 
magnification image of proximal cut-site of Frog 2. [C] Low magnification image of center of defect of 
Frog 1. [D] Low magnification image of center of defect of Frog 2. [E] High magnification image (6X) of 
[B] showing blood (red arrow) and dying muscle cells (yellow arrow). [F] High magnification image (5X) 
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of [C] displaying the intensity of blood (red arrow) and surrounding dying muscle cells (yellow arrow). 
Black scale bars represent 1 mm in [A], [B] and [D] and 500 µm in [C]. 
 
 
3.3.2 CSD at 1 Week with HDDA Scaffold and Growth Factors (BMP4 
and VEGF) 
 
Sample Frog 1 Frog 2 Frog 3 Frog 4 
Critical Size 
Defect 
46% 42% 52% 49% 
Proximal cut-
site 
Blood, few immune 
cells present 
Blood, immune 
cells present 
Blood, immune 
cells present 
Blood, immune 
cells present 
Center of 
Defect 
Blood vessels 
forming in core of 
scaffold, fibroblasts 
laying down 
connective tissue 
Blood vessels 
forming in core of 
scaffold, fibroblasts 
laying down 
connective tissue 
Blood vessels 
forming in core of 
scaffold, fibroblasts 
laying down 
connective tissue 
Large amount of 
blood present in 
core of scaffold, 
many immune 
cells present 
Distal cut-
site 
Blood, few immune 
cells present 
Blood, few immune 
cells present 
Blood, few immune 
cells present 
Blood, few 
immune cells 
present 
 
Table 5: Summary of tissue activity in the CSD with implanted HDDA scaffold loaded with growth 
factors, BMP4 and VEGF at 1 week post-surgery. 
 
Four frogs were chosen to study CSD implanted with HDDA scaffold loaded with growth factors, 
BMP4 and VEGF at 1 week post-surgery. After 1 week of implantation of HDDA scaffold loaded with 
growth factors BMP4 and VEGF, plenty of immune cells and fibroblasts are present in 3 of the 4 frogs, 
along with blood and regenerating capillaries in all 4 frogs. Even though granulation tissue has not begun 
forming yet in any of the frog limbs, the presence of a hematoma is encouraging. The scavenged muscle 
tissue around the defect site is beginning to regenerate. However, there is still no sign of fibrocartilage. 
There is no scar tissue in the defect site; instead, there are blood cells and fibroblasts clearing cellular 
debris and building fibrin clots in all 4 frogs. The cut ends of the bone seem to be providing ample 
cellular cues for cell migration since some blood cells migrated deep into the defect site even though 
blood vessels were not yet fully formed. The hollow core of the HDDA scaffold is filled with newly 
forming blood vessels in 3 of the 4 frogs.  The 4th frog is just beginning to clean out the cellular debris to 
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support formation of blood vessels inside the scaffold. The surrounding muscle tissue has started to 
regenerate and reform close to the defect site in all 4 frogs. 
 
 
 
 
         
 
A: proximal cut-site 
 
         
B: center of defect 
 
         
         C: distal cut-site 
 
 
 
 
 
 
 
 
 
Figure 21: Schematic representation of the tarsal bone system with an induced critical sized defect after 1 
week of implantation with HDDA scaffold loaded (shown in blue) with growth factors BMP4 and VEGF. 
Connective tissue formation by fibroblasts is observed in the center of the defect (shown in pink). Red 
dashed lines indicate the approximate plane of displayed histological sections. 
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Frog 1: Section A   Frog 2: Section A 
 
 
   A             B 
 
 
 
 
 
   
Frog 3: Section A   Frog 4: Section A 
   C             D 
 
 
 
 
 
 
 
Figure 22: Images of cross-sections taken at the proximal cut-sites of 4 frogs after 1 week of implantation 
of the HDDA scaffold loaded with growth factors BMP4 and VEGF. [A] Low magnification image of the 
proximal cut-site of Frog 1 showing blood and very few immune cells. [B] Low magnification image of 
the proximal cut-site of Frog 2 showing blood and immune cells in and around the cut-site. [C] Low 
magnification image of Frog 3 showing blood and immune cells surrounding the proximal cut-site. [D] 
Low magnification image of Frog 4 showing blood and plenty of immune cells around the proximal cut-
site. The scaffold in this frog limb is right next to the defect but not in the defect itself. Black scale bars 
represent 1 mm. 
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   Frog 1: Section B   Frog 2: Section B 
  A     B 
 
 
 
 
 
 
 
   Frog 3: Section B   Frog 4: Section B 
  C     D 
 
 
 
 
 
 
 
 
 
Figure 23: Low magnification images of cross-sections taken at the center of CSD in[A] Frog 1, [B] Frog 
2, [C] Frog 3 and [D] Frog 4 after 1 week of implantation of the HDDA scaffold loaded with growth 
factors BMP4 and VEGF. Black scale bars represent 1 mm. 
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  Frog 1: Section B (high mag)        Frog 2: Section B (high mag) 
     A      B 
 
 
 
 
 
 
  Frog 3: Section B (high mag)         Frog 4: Section B (high mag) 
       C      D 
 
 
 
 
 
 
 
Figure 24: High magnification images (7X) of cross-sections taken at the center of defect of [A]Frog 1, 
[B] Frog 2, [C] Frog 3 and [D] Frog 4 after 1 week of implantation of the HDDA scaffold loaded with 
growth factors BMP4 and VEGF. Large amount of immune cells are present (yellow arrows) and blood 
vessels (red arrows) are forming in the hollow core of the scaffold in all frogs. Frogs 1, 2 and 3 also have 
a large amount of connective tissue (green arrows) and fibroblasts present within the hollow core of the 
scaffold. Black scale bars represent 500 µm. 
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  Frog 1: Section C    Frog 2: Section C 
    A      B 
 
 
 
 
 
 
 
  Frog 3: Section C    Frog 4: Section C 
    C      D 
 
 
 
 
 
 
 
 
Figure 25: Images of cross-sections taken at the distal cut-site of 4 frogs after 1 week of implantation of 
the HDDA scaffold loaded with growth factors BMP4 and VEGF. Low magnification images of distal 
cut-site of [A] Frog 1, [B] Frog 2, [C] Frog 3 and [D] Frog 4, all showing residual blood and immune 
cells around the defect site. Black scale bars represent 1 mm. 
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3.3.3 Fracture at 1 Week 
 
Two frogs were chosen to study fracture at 1 week post-surgery. At 1 week, a fracture hematoma 
is clearly observed in both Frogs 1 and 2 where blood and cellular debris are being cleaned up by 
phagocytes and other immune cells. It is also clear that blood capillaries are trying to reorganize and form 
granulation tissue. Swelling of the tissue and limb itself is observed.  The surrounding muscle cells in the 
defect site in both frog limbs are intact and very few are dying or attempting to regenerate. At the fracture 
site, cells from the bone marrow are starting to migrate outward into the defect space. Since the blood 
vessels in the defect site are ruptured, the granulation tissue is avascular which is making way for 
fibrocartilaginous growth.  
 
 
 
 
         A: proximal to fracture site 
         B: fracture site 
 
 
 
 
 
 
 
Figure 26: Schematic representation of the tarsal bone system with an induced fracture defect after 1 
week. Red dashed lines indicate the approximate plane of displayed histological sections. The red section 
around the fracture site is representative of a hematoma. 
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   Frog 1: Section A         Frog 2: Section A 
          A              B 
 
 
 
 
 
 
 
    
Frog 1: Section B        Frog 2: Section B 
  C             D 
 
 
 
 
 
 
 
 
Figure 27: Low magnification images of cross-sections proximal to the fracture site of [A] Frog 1 and [B] 
Frog 2 and at the fracture site of [C] Frog 1 and [D] Frog 2 with induced fracture defects. At the fracture 
site, a large amount of blood seems to be leaking out of the ruptured blood vessels and forming 
granulation tissue which is marked by a green arrow in both frogs. The granulation tissue being formed by 
fibrin clots is organized by growing capillaries. Black scale bars represent 1 mm. 
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3.4 Long Bone Regeneration at 2 Weeks 
 
3.4.1 CSD at 2 Weeks 
 
Samples Frog 1 Frog 2 Frog 3 Frog 4 
Critical Size 
Defect 
54% 51% 49% 41% 
Proximal cut-
site 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Center of Defect Blood present, 
highly 
disorganized 
fibrotic tissue 
Blood present, 
highly 
disorganized 
fibrotic tissue 
Highly 
disorganized 
fibrotic tissue 
Blood present, 
highly organized 
fibrotic tissue 
Distal cut-site Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
 
Table 6: Summary of tissue activity in the CSD at 2 weeks post-surgery. 
 
Four frogs were chosen to study CSD at 2 weeks post-surgery. By 2 weeks, the first cartilage 
response can be seen. The cartilage formation is around the cut-sites mushrooming backward toward the 
epiphyses of the cut tarsal bone in all 4 frogs. Around the cut-site are also regenerating muscle cells as 
well as nerves and vasculature in all 4 frogs. Surrounding the cartilage response are small clusters of 
blood and immune cells, cleaning up the leftover cellular debris and possibly encouraging the cartilage to 
expand. However, the defect is too large; the minimal cartilage response around the proximal cut-site is 
unable to bridge the gap across to the distal cut-site and is therefore unable to grow away from the cut-site 
and into the defect space in all 4 frogs. Cartilage is present only around the cut-sites due to the existing 
cells leaching out of the bone marrow into the defect and providing cellular cues to attempt to bridge the 
gap as one would observe in a fracture. Therefore, it can be seen that the fracture mechanisms are 
initiating an attempt to bridge the gap with cartilage; however, the center of the defect has no cellular cues 
to transform to cartilage as seen in all 4 frog limbs. A large amount of unorganized fibrous and scar tissue 
has formed in Frogs 1, 2 and 3 with fair amounts of vasculature growth as an attempt to provide the 
optimal biological environment for the tissue to grow into cartilage. In Frog 4, however, highly organized 
fibrous tissue can be seen which may or may not transform into cartilage during later stages. 
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        A: proximal cut-site 
 
        B: center of defect 
       
 
 
 
 
 
 
Figure 28: Schematic representation of a critical size defect in the frog tarsal bone with the mushrooming 
of cartilage around the cut-sites (in light purple) at 2 weeks post-surgery. 
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Frog 1: Section A (high mag)      Frog 2: Section A (high mag) 
 
     A       B 
 
 
 
 
 
  Frog 3: Section A (high mag)        Frog 4: Section A (high mag) 
 
  C         D 
 
 
 
 
 
 
Figure 29: High magnification (5X) images of stained histological sections at the proximal cut sites of [A] 
Frog 1, [B] Frog 2, [C] Frog 3 and [D] Frog 4 with the apparent mushrooming of cartilage around the 
tarsal bone with the defect after 1 week of induced critical sized defects. Cartilage is marked by the 
yellow arrows. Black scale bars represent 1 mm. 
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  Frog 1: Section B    Frog 2: Section B 
   A                B 
 
 
 
 
   
Frog 3: Section B    Frog 4: Section B 
   C                D 
 
 
 
 
 
 
Figure 30: Low magnification images of histological cross-sections in the central diaphyseal region of the 
critical size defects of the tarsal bone in [A] Frog 1 showing blood and highly disorganized fibrotic tissue 
(yellow circle), [B] Frog 2 showing blood and highly disorganized fibrotic tissue (yellow circle), [C] Frog 
3 showing highly disorganized fibrotic tissue (yellow circle) and [D] Frog 4 showing blood and highly 
organized fibrotic tissue (yellow circle). Black scale bars represent 1 mm.   
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3.4.2 CSD at 2 Weeks with HDDA Scaffold and Growth Factors (BMP4 
and VEGF) 
 
Sample Frog 1 Frog 2 Frog 3 Frog 4 
Critical Size 
Defect 
45% 48% 55% 55% 
Proximal cut-
site 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Center of 
Defect 
Connective tissue 
in the core of 
scaffold, 
premature 
cartilage 
surrounding 
scaffold 
Blood in the core 
of the scaffold, 
premature 
cartilage and 
connective tissue 
surrounding 
scaffold 
Connective tissue 
in the core of 
scaffold, 
premature 
cartilage 
surrounding 
scaffold 
Connective tissue 
in the core of 
scaffold (scaffold 
pushed aside), 
mature cartilage 
in defect site 
Distal cut-site Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
 
Table 7: Summary of tissue activity in the CSD with implanted HDDA scaffold loaded with growth 
factors, BMP4 and VEGF at 2 weeks post-surgery. 
 
 
Four frogs were chosen to study CSD implanted with HDDA scaffold loaded with growth factors 
BMP4 and VEGF at 2 weeks post-surgery. Once again, at 2 weeks, mushrooming of cartilage around the 
cut-site of the CSD in all 4 frog limbs is observed.  The proximal cut-site of the tarsus shows a significant 
amount of cartilage around the bone and the scaffold in all 4 frogs. At the central diaphyseal defect site, 
there is a noteworthy regeneration response. Frogs 1 and 2 have laid down connective tissue within the 
hollow core of the scaffold which has given rise to premature cartilage formation surrounding the scaffold 
in the defect site. Although Frog 2 has a large amount of blood present in the hollow core of the scaffold, 
a combination of connective tissue and premature cartilage is seen surrounding the scaffold in the center 
of the defect. Frog 4 has an ideal regeneration response where even though the scaffold was pushed aside 
from the center of the defect, mature cartilage has formed and new blood vessels seem to be invading the 
tissue.  Also, in the defect site and in the inner portions of the hollow core of the HDDA scaffold, the 
formation of many new blood vessels is apparent. This angiogenesis might be due to the fact that HDDA 
scaffold was soaked in VEGF prior to being implanted, and the VEGF is now taking effect and forming 
new vasculature.  
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A: proximal cut-site 
  
 
 
         B: center of defect 
 
 
 
 
 
 
Figure 31: Schematic representation of the tarsal bone system with an induced critical sized defect after 2 
weeks of implantation with HDDA scaffold loaded (shown in blue) with growth factors BMP4 and 
VEGF. Connective tissue formation by fibroblasts is observed in the center of the defect in the hollow 
core of the scaffold (shown in pink) and cartilage (shown in light purple) is seen around the cut-sites as 
well as surrounding the scaffold. Red dashed lines indicate the approximate plane of displayed 
histological sections. 
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   Frog 1: Section A   Frog 2: Section A 
  A     B 
 
 
 
 
    
Frog 3: Section A   Frog 4: Section A 
  C     D  
 
 
 
 
 
 
Figure 32: Low magnification images of cross-sections taken at the proximal cut-site of [A] Frog 1, [B] 
Frog 2, [C] Frog 3 and [D] Frog 4 after 2 weeks of implantation with an HDDA scaffold loaded with 
growth factors BMP4 and VEGF in the CSD. The mushrooming of cartilage can be seen here as marked 
by yellow arrows around the proximal cut-site of the tarsal bone with the induced CSD. Black scale bars 
represent 1 mm. 
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Frog 1: Section B (high mag)  Frog 2: Section B (high mag) 
      A B  
 
 
 
 
   
Frog 3: Section B (high mag)  Frog 4: Section B (high mag) 
      C D 
 
 
 
 
 
 
Figure 33: High magnification (5X) images of 4 frog limbs of the central portion in the hollow core of the 
HDDA scaffold 2 weeks after implantation with growth factors, BMP4 and VEGF. Red arrows are 
pointing to the connective tissue. Yellow arrows are pointing to premature cartilage formation in [A] Frog 
1, [B] Frog 2, [C] Frog 3 and mature cartilage formation in [D] Frog 4. Frogs 1, 2 and 3 all show blood 
vessel and connective tissue formation. Frog 4 only has blood vessel formation and mature cartilage next 
to the scaffold that has been pushed away from the defect site. Black scale bars represent 500 µm. 
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3.4.3 Fracture at 2 Weeks 
 
Two frogs were chosen to study fracture at 2 weeks post-surgery. By 2 weeks, a large callus of 
fibrocartilage has formed around the fracture site in both frogs. This is evident from the histological 
sections seen below. This is a soft callus since chondroblasts have just begun to lay down cartilage as a 
precursor to bone. The tissue around the fracture site is avascular with healthy chondrocytes and a 
minimal amount of immune cells. Thus, endochondral ossification has begun with the formation of a soft 
fibrocartilaginous callus around the fracture site which seems to have started by the cells in the bone 
marrow. The bone marrow hosts a variety of cells such as hematopoietic stem cells, red blood cells, 
adipose cells, etc. These seem to be migrating outward around the fracture site and aiding in the formation 
of cartilage. 
 
 
 
 
 
         A: proximal to fracture site 
         B: fracture site 
 
 
 
 
 
 
 
Figure 34: Schematic representation of a frog limb with an induced fracture in a tarsal bone 2 weeks post-
surgery. Bone is represented by the brown area whereas fibrocartilage is represented by the purple area. 
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   Frog 1: Section A         Frog 2: Section A 
 
   A     B 
 
 
 
 
 
 
   Frog 1: Section B         Frog 2: Section B 
   C     D 
 
 
 
 
 
 
 
 
Figure 35: Low magnification images of cross-sections with induced fractures 2 weeks post-surgery in 
[A] Frog 1 proximal to fracture site, [B] Frog 2 proximal to fracture site, [C] Frog 1 at fracture site and 
[D] Frog 2 at fracture site. The fracture site is surrounded by a large fibrocartilaginous soft callus outlined 
in yellow circles. Black scale bar represents 1 mm. 
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3.5  Long Bone Regeneration at 3 Weeks 
 
 3.5.1 CSD at 3 Weeks 
 
 
 
Sample Frog 1 Frog 2 Frog 3 Frog 4 
Critical Size 
Defect 
47% 43% 54% 51% 
Proximal cut-
site 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Center of Defect Disorganized 
fibrous, scar tissue 
Disorganized 
fibrous, scar tissue 
Disorganized 
fibrous, scar tissue 
Some connective 
tissue 
Distal cut-site Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
Mushrooming of 
cartilage 
 
Table 8: Summary of tissue activity in the CSD at 3 weeks post-surgery. 
 
Four frogs were chosen to study CSD at 3 weeks post-surgery. In 3 weeks, the CSD of the frog 
hind limb does not appear to be very different than the CSD at 2 weeks. The same mushrooming effect of 
cartilage around the cut sites of the operated tarsuses can be seen in all 4 frogs. However, in the central 
defect region, there is no cartilage formation. Since blood vessels are not present, and are not being 
formed, the diffusion of nutrients to the central portion of the defect site is unlikely. Hence, cartilage is 
not able to fill in the gap between the two cut ends of the tarsal bone in all 4 frogs. Surrounding muscle 
cells are also slowly beginning to die since they do not have a bone to attach to. Some immune cells are 
present at this stage, showing that most of the cellular debris produced from the defect are being digested 
and fibrous, scar tissue is forming in the defect site in all 4 frogs.  
 
A: proximal cut-site 
 
     B: center of defect 
 
 
Figure 36 (left): Schematic representation of an induced CSD in 
frog limb 3 weeks post-surgery with mushrooming of cartilage at 
cut-sites shown in light purple. 
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   Frog 1: Section A   Frog 2: Section A 
 
        A        B 
 
 
 
 
 
 
   Frog 3: Section A   Frog 4: Section A 
 
       C        D 
 
 
 
 
 
 
Figure 37: High magnitude images (5X) of cross-sections of the proximal cut-sites in [A] Frog 1, [B] 
Frog 2, [C] Frog 3 and [D] Frog 4 with induced critical size defects after 3 weeks. Mushrooming of 
cartilage is seen once again in all 4 cases at the proximal cut-sites which is shown with yellow arrows. 
Black scale bars represent 1 mm. 
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         Frog 1: Section B          Frog 2: Section B 
        A       B 
 
 
 
 
 
          Frog 3: Section B           Frog 4: Section B 
         C      D 
 
 
 
 
 
 
Figure 38: Low magnification images of cross-sections of the center of the defect in induced critical size 
defects in 4 frogs after 3 weeks. Central defects sites of [A] Frog 1, [B] Frog 2, [C] Frog 3 all show 
fibrous scar tissue formation (yellow circles) in the center of the defect. [D] The center of the defect in 
Frog 4 shows connective tissue formation in the defect site, however, no cartilage formation is seen. None 
of the defects are bridged with cartilage and many immune cells are still present in the defect site. Black 
scale bars represent 1 mm. 
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3.5.2 CSD at 3 Weeks with HDDA Scaffold and Growth Factors (BMP4 
and VEGF) 
 
Sample Frog 1 Frog 2 Frog 3 Frog 4 
Critical Size 
Defect 
54% 45% 51% 53% 
Proximal cut-
site 
Cartilage 
formation 
Cartilage 
formation 
Cartilage 
formation 
Cartilage 
formation 
Center of Defect Premature 
Cartilage 
formation 
Cartilage 
formation 
Cartilage 
formation 
Cartilage 
formation 
Distal cut-site Cartilage 
formation 
Cartilage 
formation 
Cartilage 
formation 
Cartilage 
formation 
 
Table 9: Summary of tissue activity in the CSD with implanted HDDA scaffold loaded with growth 
factors, BMP4 and VEGF at 3 weeks post-surgery. 
 
Four frogs were chosen to study CSD implanted with HDDA scaffold loaded with growth factors 
BMP4 and VEGF at 3 weeks post-surgery. At 3 weeks, the entire critical size defect is filled with large 
amounts of cartilage tissue in all 4 frogs. Frogs 2, 3 and 4 have bridged the gap with mature cartilage 
while Frog 1 has bridged its gap with premature cartilage. The mushroomed cartilage around the cut ends 
of the bone has grown and filled in the gap. This tissue is more organized and directed. Sometime 
between 2 weeks and 3 weeks, the fibrous nature of the critical size defect with the scaffold became more 
cartilaginous. The BMP4 seemed to have induced an endochondral response requiring the cells to bridge 
the entire gap with cartilage. The HDDA scaffold is still intact and in the hollow core of the scaffold, 
networks of connective tissue infiltrated the pores and a few blood vessels can be seen. Surrounding the 
scaffold and the large cartilage ring are healthy and regenerating muscle cells. Not only did the cartilage 
form, but surrounding muscle cells, the interosseous ligament, nerve tissue and blood vessels seem to be 
reattaching to the defect site with cartilage.  
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A: proximal cut-site 
 
    B: center of defect 
 
C: distal cut-site 
 
 
 
 
Figure 39: Schematic representation of frog tarsal bone with induced critical size defect implanted with 
HDDA scaffold (represented by the blue cylinder) loaded with BMP4 and VEGF after 3 weeks. The 
purple area represents cartilage while the brown represents bone. Red dashed lines indicate the 
approximate plane of displayed histological cross-sections. 
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  Frog 1: Section A    Frog 2: Section A 
 A            B 
 
 
 
 
 
 
   
Frog 3: Section B    Frog 4: Section B 
     C             D 
 
 
 
 
 
 
 
 
Figure 40: Low magnification images of cross-sections of proximal cut-sites of tarsal bones in 4 frogs 
after implantation of HDDA scaffold loaded with growth factors BMP4 and VEGF 3 weeks post-surgery. 
Yellow circles mark cartilage rings around the cut-sites of the bone in [A] Frog 1, [B] Frog 2, [C] Frog 3 
and [D] Frog 4.  Black scale bar represents 1 mm. 
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  Frog 1: Section B (high mag)   Frog 2: Section B (high mag) 
     A            B 
 
 
 
 
 
  Frog 3: Section B (high mag)   Frog 4: Section B (high mag) 
      C            D 
 
 
 
 
 
 
 
Figure 41: High magnification images (5X) of center of defect in [A] Frog 1 showing a ring of premature 
cartilage around the scaffold, [B] Frog 2 showing a ring of mature cartilage around the scaffold, [C] Frog 
3 showing an area of mature cartilage in the defect space where the scaffold was implanted but was later 
pushed away by the frog limb, and [D] Frog 4 showing a ring of mature cartilage around the scaffold 3 
weeks post-surgery. Frogs 2, 3 and 4 have successfully bridged the CSD with mature cartilage 
surrounding the scaffolds. Frog 1 is just starting to lay down premature cartilage in and around the hollow 
core of its scaffold. Black scale bars represent 1 mm in [A], [B] and [C] and 0.5 mm in [D]. 
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            Frog 1: Section C    Frog 2: Section C 
      A        B 
 
 
 
 
 
 
 
    
Frog 3: Section C   Frog 4: Section C 
       C        D 
 
 
 
 
 
 
 
 
Figure 42: Images of cross-sections taken at the distal cut-sites of the tarsal bones induced with critical 
sized defects and implanted with HDDA scaffolds loaded with growth factors BMP4 and VEGF 3 weeks 
post-surgery. Yellow rings show cartilage surrounding the distal cut-site of the bone in [A] Frog 1, [B] 
Frog 2, [C] Frog 3 and [D] Frog 4. The gaps in all 4 frogs have successfully been bridged with cartilage 
(Frogs 2, 3 and 4) and premature cartilage (Frog 1). Black scale bars represent 1 mm. 
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3.5.3 Fracture at 3 Weeks 
 
Two frogs were chosen to study fracture at 3 weeks post-surgery. By 3 weeks, a large cartilage 
callus has been formed around the fracture site in both frogs.  There is absolutely no sign of any more 
blood vessel formation or penetration in the defect site in both frogs. The avascular cartilage that has been 
mushrooming around the fracture site has now crept all the way up to the epiphyses of injured tarsal bone. 
Very soon, endochondral ossification processes are expected to remodel this large chunk of cartilage 
around the fracture site into a narrow rod which will then eventually be ossified into primary bone.  
 
 
 
              A: proximal to fracture site 
         
B: fracture site 
 
 
 
 
 
 
 
Figure 43: Schematic representation of tarsal bone with induced fracture after 3 week in the frog limb. 
The purple area represents the cartilage callus around the bone represented in the brown area. Red dashed 
lines are approximate planes of displayed histological sections. 
 
 
 
 
 
61 
 
  Frog 1: Section A    Frog 2: Section A  
      A              B 
 
 
 
 
 
 
 
 
  Frog 1: Section B    Frog 2: Section B 
 
        C      D 
 
 
 
 
 
 
 
 
 
Figure 44: Low magnification images of cross-sections taken proximal to the fracture site of [A] Frog 1 
and [B] Frog 2 and at the fracture site of [C] Frog 1 and [D] Frog 2 at 3 weeks showing the large cartilage 
calluses (yellow circles). Black scale bars represent 1 mm. 
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3.6 Long Bone Regeneration Using Zein Scaffolds 
3.6.1 CSD at 2 Weeks with Zein Scaffold and Growth Factors (BMP4 
and FGF10)  
 
 
 
Sample Frog 1 Frog 2 Frog 3 Frog 4 
Critical Size 
Defect 
50% 51% 42% 49% 
Proximal cut-site Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around cut end of 
bone 
Center of Defect Scaffold 
surrounded by wall 
of immune cells 
mixed with 
premature 
cartilage 
Scaffold pushed 
out of defect, 
defect site filled 
with mixture of 
immune cells and 
premature 
cartilage 
Scaffold 
surrounded by wall 
of immune cells 
mixed with 
premature 
cartilage 
Scaffold 
surrounded by wall 
of immune cells 
mixed with 
premature 
cartilage 
Distal cut-site Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around cut end of 
bone 
 
Table 10: Summary of tissue activity in the CSD with implanted zein scaffold loaded with growth factors, 
BMP4 and FGF10 at 2 weeks post-surgery. 
 
 
Four frogs were chosen to study CSD implanted with zein scaffold loaded with growth factors 
BMP4 and FGF10 at 2 weeks post-surgery. After 2 weeks of implantation of the novel zein scaffold, there 
is a large area of a tissue which is a mixture of premature cartilage and immune cells that formed around 
the scaffold and bridged the CSD that was induced in the tarsus of the frog hind limb. The mushrooming 
of cartilage around the cut sites of the injured tarsal bone that was observed at 2 weeks using the HDDA 
scaffold is also present in this case. The zein scaffold was pushed out through the surgical sutures in all 
frogs; but, shards of the scaffold remained in the critical size defect in Frogs 1, 3 and 4. Frog 2 rejected 
the scaffold completely and was extruded out through the sutured opening in the skin from the surgery. 
There are a few blood cells and many immune cells present, mixed with few premature cartilage cells in 
the center of the defect in all frogs surrounding the scaffold. Frogs 1 and 3 especially show walls of 
immune cells surrounding the shards of the zein scaffold and also few premature cartilage cells mixed in 
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with the immune response. The surrounding muscle cells are not entirely healthy but show some signs of 
regeneration. Frog 4’s defect site showed very healthy muscle cells surrounding the scaffold and 
infiltrated cellular material which proves that even though the scaffold is not present, regeneration is still 
taking place. The combination of FGF10 and BMP4 seems to be a better choice for the zein scaffold since 
the cartilage response to the defect site was observed at only 2 weeks using the FGF10 and BMP4 
combination as compared to the cartilage response seen at 3 weeks using VEGF and BMP4 in the HDDA 
scaffold. The lack of VEGF seems to show minimal blood vessel formation; however, zein being a 
foreign protein eluded a large immune reaction in the frog limb.  
 
         
 
     
 Section A: proximal cut-site  
 
         
        Section B: center of defect 
 
 
 
         
 
Section C: distal cut-site 
 
 
 
Figure 45: Schematic representation of the tarsal bone system with an induced critical size defect at 2 
weeks after implantation of the zein scaffold loaded with growth factors BMP4 and FGF10. The purple 
area represents mature cartilage while the brown represents bone. The red border of the scaffold 
represents the immune cells that are walling off the scaffold and the dark pink area in the center of the 
scaffold shows a mixture of a large amount of immune cells and a few premature cartilage cells. Dark red 
dashed lines indicate the approximate plane of displayed histological cross-sections. 
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Frog 1: Section A   Frog 2: Section A    
  
A     B  
 
 
 
 
   
Frog 3: Section A   Frog 4: Section A 
 C     D       
 
 
 
 
 
Figure 46: Low magnification images of cross-sections taken at the proximal cut-site of [A] Frog 1, 
[B]Frog 2, [C] Frog 3 and [D] Frog 4 after 2 weeks of implantation of the zein scaffold loaded with 
growth factors BMP4 and FGF10. Yellow arrows show the rings of cartilage around the bone’s proximal 
cut site and green arrows show shards of the leftover zein scaffolds. Black scale bars represent 1 mm. 
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  Frog 1: section A (high mag)         Frog 2: section A (high mag) 
 A              B      
  
 
 
 
 
        Frog 3: section A (high mag)        Frog 4: section A (high mag) 
 C       D 
       
 
 
 
 
Figure 47: High magnification images (5X) of cross-sections taken at the proximal cut-site of [A] Frog 1, 
[B] Frog 2, [C] Frog 3 and [D] Frog 4 after 2 weeks of zein scaffold implantation loaded with growth 
factors BMP4 and FGF10. Yellow arrows show the formation of cartilage around the bone’s proximal cut 
site and green arrows show shards of the leftover zein scaffolds. Black scale bars represent 1 mm.  
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  Frog 1: section B       Frog 2: section B 
 A           B 
 
 
 
 
  Frog 3: section B          Frog 4: section B 
 C           D 
 
 
 
 
 
 
Figure 48: Images of cross-sections taken at the center of critical sized defects of [A] Frog1, [B] Frog 2, 
[C] Frog 3, and [D] Frog 4 after 2 weeks of zein scaffold implantation loaded with growth factors BMP4 
and FGF10. Yellow arrows show the formation of tissue with a mixture of cells of premature cartilage 
and immune cells in the defect site. Black scale bars represent 1 mm. 
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      Frog 1: section B (high mag)           Frog 2: section B (high mag) 
        A       B 
 
 
 
 
 Frog 3: section B (high mag)          Frog 4: section B (high mag) 
       C               D 
 
 
 
 
 
 
 
Figure 49: High magnification images (7X) of cross-sections taken at center of defects of 4 frogs after 2 
weeks of zein scaffold implantation loaded with growth factors BMP4 and FGF10. Yellow arrows show 
tissue that is a mixture of premature cartilage and a large amount of immune cells in the defect site.[A] 
There is a shard of the zein scaffold remaining in the center of the defect in Frog 1 which is surrounded 
by layer of mostly immune cells mixed with few premature cartilage cells. [B] The red arrow in Frog 2’s 
section B shows the site of scaffold rejection where the zein scaffold was pushed out through the opening 
in the skin that was induced during surgery and the yellow arrows are pointing to tissue that has a host of 
immune cells mixed with few premature cartilage cells. [C] Frog 3 also shows similar tissue although the 
number of premature cells seems to be greater in this case than immune cells. [D] Frog 4 also shows 
similar tissue. Black scale bars represent 1 mm.  
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  Frog 1: section C    Frog 2: section C 
   A      B 
 
 
 
 
 
  Frog 3: section C    Frog 4: section C 
   C      D 
 
 
 
 
 
 
 
Figure 50: Low magnification images of cross-sections taken at the distal cut-site of [A] Frog 1 [B] Frog 
2, [C] Frog 3 and [D] Frog 4 after 2 weeks of implantation of the zein scaffold loaded with growth factors 
BMP4 and FGF10. Yellow arrows are showing the rings of cartilage around the bone’s distal cut site and 
green arrows are showing shards of the leftover zein scaffolds. Black scale bars represent 1 mm. 
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3.6.2 CSD at 6 Weeks with Zein Scaffold and Growth Factors (BMP4 
and FGF10)  
 
Sample Frog 1 Frog 2 Frog 3 (stress 
fracture) 
Frog 4 (stress 
fracture) 
Critical size 
defect 
59% 44% 33% 32% 
 
 
 
Proximal cut-
site 
Ring of cartilage 
around the cut end 
of the bone, very 
large immune 
response at the site 
of scaffold 
Ring of cartilage 
around the cut end 
of the bone, very 
large immune 
response at the site 
of scaffold 
Ring of cartilage 
around both the 
cut end of the bone 
as well as the 
fractured bone, 
wall of immune 
cells around 
scaffold 
Ring of cartilage 
around the cut end 
of the bone, wall 
of immune cells 
around scaffold 
 
 
 
Center of defect 
Large area of 
premature 
cartilage and 
immune cells, 
scaffold pushed 
out 
Mixture of 
cartilage and 
immune cells and 
newly forming 
blood vessels in 
the hollow core of 
scaffold 
Large area of  
cartilage in defect 
site and large ring 
of cartilage around 
fractured bone, 
first island of 
ossification 
observed in the 
center of defect 
Large area of  
cartilage in defect 
site and large ring 
of cartilage around 
fractured bone 
 
 
Distal cut-site 
Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around cut end of 
bone 
Ring of cartilage 
around both the 
cut end of the bone 
as well as the 
fractured bone 
Ring of cartilage 
around both the 
cut end of the bone 
as well as the 
fractured bone 
 
Table 11: Summary of tissue activity in the CSD with implanted zein scaffold loaded with growth factors, 
BMP4 and FGF10 at 6 weeks post-surgery. 
 
Four frogs were chosen to study CSD implanted with zein scaffold loaded with growth factors 
BMP4 and FGF10 at 6 weeks post-surgery. Six weeks after implanting the zein scaffold, 2 of the 4 frogs 
had suffered stress fractures in the intact tarsal bone. Frogs 1 and 2 displayed regeneration responses by 
bridging the critical size defects by a mixture of cartilage and immune cells similar to cases observed at 2 
weeks. Frog 1 has large islands of premature cartilage forming in the center of the defect and Frog 2 has 
blood vessels surrounded by marrow material and connective tissue along with cartilage formation in the 
hollow core of the scaffold in the center of the defect after 6 weeks of implantation of the zein scaffold.  
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Frogs 3 and 4 suffered from stress fractures. Since the frogs do not have any external stabilizers 
to control their motion using their hind limbs, the mechanical loads that the tarsal bone system absorbed 
were all probably taken up by the intact tarsal bone without the induced critical size defect. Hence, the 
frogs ultimately had stress fractures in the intact tarsuses due to the absence of a significant portion of 
bone in the operated tarsus. This caused the critical size defect to shorten in length and a major 
regeneration response was seen in the frog limb.  
Surprisingly, the zein scaffold was actually rejected by Frogs 1, 3 and 4 since its dimensions were 
a little larger than its tarsus bone structure. The frogs pushed out majority of the scaffold by week 3 
through the sutured area after surgery. However, shards of the scaffold still remain inside the limbs in 
some frogs. The formation of cartilage around both bones was observed due to the CSD and the stress 
fracture in this case. Cartilage bridged the gap in the bone with the CSD and formed around the cut sites 
mushrooming back toward the metaphyses as seen before. The tarsal bone with the stress fracture has a 
large ring of cartilage surrounding the fracture site, but not a significant amount of cartilage was observed 
around the metaphysis of the fractured bone. Also, Frog 3 showed an initial island of ossification in the 
center of the defect where newly formed bone is nestled within the ring of cartilage. Therefore, it is 
evident that the frog limb is attempting to regenerate both the stress fracture and the CSD simultaneously 
and endochondral ossification has finally begun in Frog 3 [Figure 57]. 
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Figure 51: Schematic representations of the tarsal bone system with (i) induced critical size defects at 6 
weeks after implantation of the zein scaffold loaded with growth factors BMP4 and FGF10 without stress 
fracture and (ii) with a stress fracture in the intact tarsal bone. The purple area represents cartilage while 
the brown represents bone. The red border of the scaffold represents the immune cells that are walling off 
the scaffold and the dark pink area in the center of the scaffold shows a mixture of a large amount of 
immune cells and a few premature cartilage cells. Red dashed lines indicate the approximate plane of 
displayed histological cross-sections. 
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Figure 52: Low magnification images of cross-sections taken at the proximal cut-site of 4 frogs after 6 
weeks of implantation of the zein scaffold loaded with growth factors BMP4 and FGF10. [A] The 
proximal cut-site in Frog 1 shows cartilage formation (yellow arrow) and large areas of immune cells (red 
arrows) at the site of scaffold. [B] The proximal cut-site in Frog 2 shows ring of cartilage around 
proximal cut-site (yellow arrow) and large area of immune cells (red arrows) at the site of scaffold. [C] 
Proximal cut-site in Frog 3 showing cartilage mushrooming (yellow arrow). Shard of the scaffold is left 
behind which is walled off by immune cells (green arrow). [D] Yellow arrows show the mushrooming of 
cartilage around the operated bone as well as the fractured bone and green arrows show site of the zein 
scaffold surrounded by a host of immune cells. Frogs 1 and 2 do not have stress fractures whereas Frogs 3 
and 4 contain stress fractures. Black scale bars represent 1 mm.  
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 A             B 
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Figure 53: Low magnification images of cross-sections taken at the center of defects of 4 frogs after 6 
weeks of implantation of the zein scaffold loaded with growth factors BMP4 and FGF10. [A] The center 
of the defect of Frog 1 showing a granular mixture of cartilage and large amount of immune cells (yellow 
arrow). [B] The center of the defect of Frog 2 showing intact scaffold (green arrow) with newly forming 
blood vessels and a mixture of cartilage and immune cells (yellow arrow) in the hollow core of the 
scaffold.  [C] Center of defect of Frog 3 with stress fracture showing rings of cartilage (yellow arrow) in 
the defect site (red circle) as well as around the fractured bone (green circle). The red arrow is pointing to 
the first island of ossification occurring in the center of the defect. Black scale bars represent 1 mm.  [D] 
Center of defect of Frog 4 with stress fracture showing rings of cartilage (yellow arrow) in the defect site 
(red circle) as well as around the fractured bone (green circle).  
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        Frog 1: Section B (high mag) 
  
 
 
 
 
 
 
 
 
 
Figure 54: High magnification image (5X) of the center of the defect of Frog 1 showing premature 
cartilage formation (yellow arrows) and large number of immune cells (red arrows). Black scale bar 
represents 1 mm.  
 
 
 
 
 
 
 
 
Frog 2: Section B (high mag) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55: High magnification image (5X) of center of defect of Frog 2 showing intact scaffold (green 
arrow), a mixture of cartilage and immune cells in the hollow core of the scaffold (yellow arrows) and 
newly forming blood vessels in the hollow core of the scaffold (red arrows). Muscle tissue surrounding 
the scaffold is very healthy and intact. Black scale bar represents 1 mm. 
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  Frog 1: Section C    Frog 2: Section C 
 
     A              B 
 
 
 
 
 
 
 
 
 
 
 
 
  Frog 3: Section F    Frog 4: Section F 
 
 
     C            D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 56: Low magnification images of cross-sections taken at the distal cut-site of [A] Frog 1 showing 
ring of cartilage around the cut-site (yellow arrow), [B] Frog 2 showing cartilage around cut-site (yellow 
arrow), [C] Frog 3 with stress fracture showing rings of cartilage around both the operated (red circle) and 
fractured bone (green circle) and [D] Frog 4 with stress fracture showing rings of cartilage around both 
the operated (red circle) and fractured bone (green circle). Black scale bars represent 1 mm. 
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Figure 57: High magnification image (7X) of the center of defect of Frog 3 showing the island of newly 
ossifying cartilage (green arrow) surrounded by mature cartilage (yellow arrow).  
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Chapter 4: Discussion 
 
In order to study regeneration mechanisms in critical size defects in the Xenopus Laevis, it is vital 
to first look at cellular activity in fracture repair in order to analyze why it is possible for the limb to 
naturally heal a discontinuity or a small defect but impossible to regenerate a larger section of the bone 
tissue that has been excised. Once the cells that are responsible for fracture have been carefully studied, it 
is then important to discover which cellular mechanisms are present in fracture repair that can be 
mimicked in order to bridge a critical size defect gap. Most studies involving bone regeneration take a 
direct bone deposition approach where instead of following in the footsteps of fracture healing or 
developmental regeneration, a biomaterial loaded with a choice of soluble factors or some sort of graft is 
implanted in the bone defect with hope that the defect will subsequently ossify. However, this study aims 
to design a biomaterial that is not only designed to deliver the right soluble factors to the defect site, but 
also to analyze whether or not the implanted biomaterial in vivo triggers cellular responses that are 
identical to those seen in fracture healing or developmental regeneration.  
 
 
4.1 Xenopus Laevis Animal Model 
 
 
The Xenopus Laevis species, more commonly known as the African clawed frog, was used in this 
study for a variety of reasons. Firstly, a post-surgery requirement such as external stabilization is not 
essential for these frogs. Most mammalian models such as rats or mice require external stabilizers in order 
to minimize movement of the limbs. The frogs minimize limb movements by themselves due to pain after 
surgery. Secondly, the cost of obtaining these frogs is minimal. Thirdly, caring for these animals is 
relatively very easy. Many observations can be made just by monitoring their habitat; for example, a 
scaffold that has been pushed out of the limb through the surgical sutures may easily be seen in the bin 
containing the amphibian aqueous solution and the frog. Also, the movements of the frogs can be closely 
observed by checking their ability to swim and swelling in their limbs. The amount of feed a frog is able 
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to ingest is also a good indication of the health of the frog. In addition, the critical size defect of the 
Xenopus Laevis tarsal bone is approximately 35% whereas the critical size defect of most mammalian 
long bones is 20%. Therefore, if the biological phenomena are similar, bridging of the defects in both 
cases may be achieved. Similar to mature mammals, adult Xenopus Laevis frogs fail to repair large 
defects but readily heal fractures. Hence, it can be concluded that most biological healing processes 
across both species are very similar. 
 
 
4.2 Scaffold Choices 
 
 
The HDDA scaffold and the zein scaffolds used in this study were carefully chosen after 
examining many important aspects. The HDDA scaffold is a polymer, similar to PEG and PLG, and is 
fabricated using a very innovative process, Projection Micro-Stereo Lithography. This process, although 
slightly cumbersome, enables us to finely control the porosity and dimensions of the scaffold. The HDDA 
scaffolds used in this study have a controlled porosity of 55% with highly organized 50 µm pores. The 
scaffold is known to be biocompatible but does not have biodegradation capabilities. The HDDA scaffold 
is still present in the frog limb post-surgery for more than 3 months if not surgically removed or pushed 
out through the sutured cut by the frog itself. The HDDA scaffolds are soft and regular enabling them to 
be symmetric and evenly dense. Their shape, geometry and growth factor transport properties can easily 
be manipulated. These aspects make the HDDA scaffold a viable choice for implantation in the frog limbs 
to study regeneration. The HDDA scaffolds efficiently transported the VEGF and BMP4 growth factors 
into the critical size defects of the frog tarsal bones. The growth factors held within these scaffolds 
leached out during the first 6 hours in vitro. However, the rate of diffusion of the growth factors in vivo is 
unknown, making it difficult to judge the optimum level of porosity during fabrication. Using gross 
approximations, it is most likely that the growth factors have diffused out of the scaffold within the first 
12 hours of implantation due to their relatively high porosity. Since the scaffolds are fabricated using 
79 
 
even porosity, the growth factors diffuse in all directions, from the inner core of the hollow cylinder to the 
surrounding tissue.  
 
In contrast, the zein scaffolds are readily made using the widely available “corn protein”, zein. 
Zein is a prolamine protein found in maize. In vitro studies have shown that zein is biocompatible since 
fibroblast adhesion to its structure show adequate promise in using them as biomaterials [35]. In vivo 
studies have also shown promise for implantation. A recent study performed by Tu et al. using zein 
scaffolds seeded with Mesenchymal Stem Cells in mice has proven to increase ectopic bone formation by 
60% in 12 weeks [36]. Additionally, zein scaffolds have also been shown to have good biocompatibility, 
blood vessel formation in the scaffold and achievable biodegradation within 8 months [37].  
 
Although the fabrication process of zein scaffolds is mostly chemically enhanced by adding 
stearic acid or oleic acid [37], these scaffolds are relatively easy to fabricate. Zein layers aggregate 
relatively quickly due to their hydrophobicity making it difficult to control their porosity during the 
fabrication process. These scaffolds typically have porosity between 8 and 10% depending on the amount 
of zein used during fabrication. However, they have highly efficient biodegradation capabilities since the 
zein protein is a natural material and by using various concentrations, its biodegradation is easily 
controlled. The shape and geometry of these scaffolds are fairly easy to control and they are quite stiff, 
but brittle. Hence, when placed in the critical size defect, their stronger structures might aid in load-
bearing and subsequently, preventing stress fractures from occurring in the non-operated tarsus since it is 
the only intact bone absorbing all mechanical stresses and strains. In this study, they also proved to be 
efficient as carriers for the growth factors, BMP4 and FGF10 since they produced a fair cartilage response 
in the critical size defect in a shorter time period of 2 weeks. Since these scaffolds are novel and not 
further investigated, the actual growth factor diffusion out of these scaffolds is unknown. However, it can 
be predicted that due to their minimal porosity and dense structures, the growth factors are most likely 
diffusing out of the scaffolds from both ends longitudinally and probably not from the hollow core 
outward, or radially. The cut ends of the bone in the critical size defect are likely receiving the growth 
80 
 
factor diffusion more than the central portion of the defect, causing a faster cellular response. This 
directional diffusion might be one reason why the cartilage response was quickly observed using the zein 
scaffolds as compared to the HDDA scaffolds. Although this particular process has not been tested, it can 
easily be said from the observed histological data that the zein scaffolds are showing viability for their use 
as biomaterials.  
 
4.3 Growth Factor Choices 
 
 
BMP4, or Bone Morphogenetic Protein 4, is a protein that is part of the TGF-β, Transforming 
Growth Factor-Beta superfamily. BMP4 was proved to be an important growth factor is the endochondral 
osteogenesis and lack of it produces diseases such as Fibrodysplasia Ossificans Progressiva. Recombinant 
BMP4 was shown to induce bone morphogenesis and cartilage in rodents when implanted subcutaneously 
or intramuscularly. It is specifically known for its ability to aid fracture repair and also tooth and limb 
regeneration but particularly for bone formation during embryogenesis [38]. Implantation of BMP(s) at 
ectopic sites has been suggested to induce cartilage formation first and then bone formation through the 
endochondral sequence [14]. In another study, BMP-4 plasmid DNA demonstrated significant bone 
growth in the rat calvarial defect model [39]. BMP4 is also one of the many growth factors that is present 
extensively during the early stages of fracture healing [10]. Therefore, BMP4 is one of the most critical 
soluble factors to induce endochondral ossification or the initiation of chondral bridging of the critical 
size defect. It is also very important for bone deposition at ectopic sites and fracture healing.  
 
VEGF, or Vascular Endothelial Growth Factor, is a soluble factor known to be exuded by tissues 
in order for the initiation of angiogenesis. VEGF is also very important for developmental neo-blood 
vessel formation as well as bone formation [40]. VEGF-loaded scaffolds also managed to increase BMD 
(bone mineral density) and bone coverage in irradiated osseous defects which demonstrates that VEGF is 
essential for neovascularization as well as repairing ruptured blood vessels in bone defects [25]. VEGF 
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delivered to osseous defects along with BMP4 showed significant increases in the amount of regenerated 
bone as compared to single growth factor delivery [21]. Therefore, VEGF combined with BMP4 in this 
case proves to be critical for bone regeneration in critical size defects.  
 
 
FGF10, or Fibroblast Growth Factor 10, is a protein or soluble factor expressed in the Fibroblast 
Growth Factor family. It is also known to be expressed mainly in fibroblasts and other keratinizing 
epidermal cells. Therefore, this growth factor was chosen to be loaded into the zein scaffolds since zein 
scaffolds displayed great promise and biocompatibility with fibroblasts [35]. FGF10 was also known to 
be expressed largely in cells undergoing wound healing processes and re-epithelialization in extracellular 
matrices, which are important biological processes during the first stage of bone regeneration [41]. It is 
also expressed in newly forming limb mesenchyme tissues and also appears to play a major role in initial 
limb bud formation and continuous limb bud outgrowth in vertebrates [42].   
 
 
4.4  Long Bone Regeneration in CSDs 
 
 
 Over the course of 3 weeks, many changes have occurred in the frog limb in order to attempt to 
bridge a critical size defect in the tarsal bone. At 3 days, structures surrounding the bone defect such as 
muscle and ligament were also severely affected and were simultaneously attempting to regenerate along 
with the bone defect. A large blood clot was present and a host of immune cells migrated into the defect 
site in order to clear the cellular debris. At 1 week, no granulation tissue or immune cells were present in 
the defect or around the cut-sites. A large amount of blood was still present and scavenged muscle cells 
were slowly being replaced by fibrotic scar tissue. At 2 weeks, a cartilage response to the bone defect was 
seen around the proximal and distal cut-sites of the tarsal bone but the chondrocytes were unable to bridge 
the large gap between the two ends. Cartilage surrounded the cut-sites and mushroomed backwards 
towards the epiphyses of the bone. At 3 weeks, a similar response was seen where cartilage mushrooming 
was evident but no cartilage was observed in the center of the defect. The central defect space was filled 
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with fibrotic scar tissue. Out of the 11 samples tested with CSDs, none of them were able to bridge the 
defect gap completely with either cartilage or bone by the end of 3 weeks. 
 
 
4.5  Long Bone Regeneration in CSDs implanted with HDDA scaffolds 
containing BMP4 and VEGF 
 
 
 During the first 3 days, all the growth factors had leached out of the scaffolds and diffused among 
the surrounding cells in the defect space. However, immune cells and blood were present due to two 
reasons: to scavenge the cellular debris in the defect and also to eat away at the foreign object, the 
polymer scaffold. This two-fold immune response delayed the process of regeneration for a few more 
days. After 1 week, regenerating capillaries, fibroblasts and connective tissue formation has been 
observed near the scaffold. VEGF is known to induce angiogenesis [29, 30] and plenty of new capillaries 
and blood vessels that have been ruptured due to the bone defect are now reforming and organizing within 
the defect space. In 2 weeks time, the first cartilage response is seen which is similar to the mushrooming 
effect observed in CSDs. There is however, no cartilage present in the center of the defect site. In the 
hollow core of the scaffold, fibroblasts and connective tissue are still present and very few immune cells 
were surrounding the scaffold. By 3 weeks, the entire defect space has been bridged with a cartilage rod 
surrounding the scaffold in the center of the defect. There is no sign of immune cells or blood. 
Surrounding muscle cells have almost completely regenerated and the interosseous ligament also has 
started to reconnect to the large cartilage rod bridging the defect. Out of the 13 samples tested, 4 samples 
have shown to bridge the CSD gap by 3 weeks with a large cartilage rod displaying significant 
regeneration. 
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4.6 Long Bone Regeneration in Fractures 
 
 
 As expected, a large blood clot formed in the fracture site in 3 days and the frog limb was 
swollen. A large number of immune cells were also present at the fracture site during this time, eating 
away at the cellular debris. In 1 week, a massive hematoma was formed around the fracture site, and 
initial formation of granulation tissue is observed. By 2 weeks, a large fibrocartilaginous soft callus had 
formed surrounding the fracture site. Minimal amount of blood and immune cells were present and 
endochondral ossification has seemed to be initiated. At 3 weeks, a large hard cartilaginous callus is 
present with no sign of blood penetration or immune response. Between 4 and 8 weeks, ossification is 
expected to take place turning the large cartilaginous callus into primary bone. Out of the 7 samples 
tested, all of them seemed to follow the expected fracture healing stages accurately.  
 
 
4.7 Long Bone Regeneration in CSDs implanted with zein scaffolds 
containing BMP4 and FGF10 
 
 
 By 2 weeks, the implanted zein scaffold has managed to bridge the critical size defect in the tarsal 
bone by premature cartilage. Zein, being a protein, produces anti-bodies when implanted in vivo causing 
many immune cells to migrate towards it. The premature cartilage surrounds the immune cells and the 
scaffold and a large number of newly forming blood vessels are observed in the center of the defect inside 
the hollow core of the scaffold. After 6 weeks, a massive cartilage response is seen where a combination 
of premature cartilage and vast number of immune cells has bridged the entire gap between the two cut 
ends of the bone. At this stage, immune cells have extensively aggregated forming walls around the 
shards of the scaffold. Additionally, one of the two frogs with stress fractures showed the very first island 
of ossification in the center of the defect marking the beginning of endochondral ossification. However, 
this may be due to the decreased length of the defect in the operated tarsus that followed the stress 
fracture in the intact tarsus. Out of the 8 samples tested, 2 of them have shown complete bridging of the 
defect site by cartilage and one of them displayed initial ossification of bone in the center of the defect 
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(note: the CSD in this case was shortened due to the presence of stress fractures which may have 
impacted the speed and quality of regeneration). The other 6 samples have shown partial bridging of the 
gap with cartilage and a large immune response but no ossification. 
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4.8 Summary 
 
 3 days 1 week 2 weeks 3 weeks 6 weeks 
 
 
 
CSD only 
 
Blood and 
immune cells 
present, 
surrounding 
structures 
heavily damaged 
Blood and 
immune cells 
present, initial 
formation of 
fibrous scar 
tissue in the 
center of defect 
Mushrooming of 
cartilage at 
proximal and 
distal cut-sites 
and formation of 
fibrotic, scar 
tissue in the 
center of defect 
Mushrooming of 
cartilage at 
proximal and 
distal cut-sites 
and formation of 
fibrous, scar 
tissue in the 
center of defect 
 
 
 
 
 
CSD + HDDA 
scaffold + 
BMP4 + VEGF 
 
 
 
Large amount of 
blood and 
immune cells 
present 
 
Blood and 
immune cells 
present, 
fibroblasts 
laying down 
connective tissue 
in the hollow 
core of the 
scaffold 
Mushrooming of 
cartilage at 
proximal and 
distal cut-sites, 
formation of 
premature 
cartilage around 
the scaffold and 
connective tissue 
inside the 
scaffold 
 
Cartilage 
formation 
bridging the gap 
from the 
proximal end to 
the distal end 
with newly 
forming blood 
vessels 
 
 
 
 
CSD + zein 
scaffold + 
BMP4 + 
FGF10 
  Cartilage 
formation 
around both cut-
sites of the 
operated bone 
and mixture of 
premature 
cartilage and 
immune cells in 
the center of 
defect 
 Large areas of 
cartilage and 
immune cells 
in the center of 
defect and 
rings of 
cartilage 
around both 
cut-sites, first 
island of 
ossification 
observed in 
reduced critical 
size defects 
 
 
 
Fracture 
Swelling of 
limb, dying 
muscle cells, 
marrow material 
providing 
cellular cues for 
fracture repair 
Fracture 
Hematoma is 
formed after a 
massive blood 
clot and 
granulation 
tissue is being 
laid down 
A large soft 
callus of 
fibrocartilage 
formed around 
the fracture site, 
very few 
immune cells 
present 
 
A large hard 
callus of 
cartilage formed 
around the 
fracture site 
 
 
Table 12: Key findings of long bone regeneration with CSD only, CSD + HDDA scaffold + BMP4 and 
VEGF, CSD + zein scaffold + BMP4 + FGF10 and fracture groups ranging from 3 days to 6 weeks. 
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Table 12 clearly shows that just with a CSD, a Xenopus Laevis long bone is unable to bridge the 
large defect naturally. The central defect site is filled with fibrotic, scar tissue. However, a CSD implanted 
with either an HDDA scaffold loaded with growth factors BMP4 and VEGF or a zein scaffold loaded 
with growth factors BMP4 and FGF10 shows cartilage formation similar to the endochondral ossification 
process seen in fracture healing. At 2 weeks, a fractured long bone is able to form a cartilaginous callus to 
bridge the small defect space. A similar reaction is seen in the CSD with scaffold implantation in 3 weeks 
with the HDDA scaffold loaded with BMP4 and VEGF and in 6 weeks with the zein scaffold loaded with 
BMP4 and FGF10. If left to heal for a longer time, the cartilage rod will eventually ossify into bone using 
the same endochondral ossification process thereby bridging the CSD to re-form the long bone.  
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Chapter 5: Conclusion 
 
 
 
 As the demand for orthopedic applications to treat small and large defects in bone is rising, 
research to design implants using optimal materials and biological factors is always in need. Events such 
as severe trauma and irradiated cancerous bone may lead to critical size defects in bone that need 
intervention via an implant since untreated long bone critical size defects lead to scarring.  Traditional 
approaches to repair long bone critical size defects involve scaffolds and direct bone deposition. 
However, the approach shown here involves bone regeneration by a method of endochondral ossification, 
a biological process similar to fracture healing and developmental regeneration, whereby formation of 
cartilage and then ossification occur to bridge defects. Histological observations demonstrate that the 
HDDA scaffold treated with VEGF and BMP4 proteins promotes cartilage formation with vascular in-
growth as soon as 2 weeks post-implantation.  Zein scaffolds loaded with BMP4 and FGF10 show 
promise since growth of cartilage is earlier but is still premature, yet ossification of cartilage is seen as 
early as 6 weeks post-implantation. 
 
 
5.1 Data Summary 
  
  
The most important aspects of long bone regeneration which aim to mimic fracture healing or 
developmental regeneration are a) the formation of cartilage and b) ossification of cartilage. The 
following table grossly summarizes the data obtained from this study to signify the regeneration 
responses obtained by using novel scaffolds and fracture healing: 
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 3 days 1 week 2 weeks 3 weeks 6 weeks 
CSD only B, I B, I, S S, C* S, C*  
CSD + HDDA scaffold + GFs B, I B, I, F C*, PC, F C  
CSD + zein scaffold + GFs   C*, PC, I  C*, C, I, O 
Fracture B, I B, I, F C C O 
 
Table 13: Summary of long bone regeneration in the Xenopus Laevis during the first 6 weeks with 
untreated CSD, CSD loaded with HDDA (loaded with growth factors BMP4 and VEGF) and zein 
scaffolds (loaded with BMP4 and FGF10) and fracture defects. B represents blood, I represents immune 
cells, S represents scar tissue, C* represents cartilage at cut-sites, PC represents premature cartilage, F 
represents connective tissue formed by fibroblasts, C represents mature cartilage and O represents 
ossification.  
 
 
 
It can be observed from the above table that the regeneration responses elicited by CSDs implanted with 
HDDA scaffolds treated with growth factors BMP4 and VEGF most closely resemble the fracture repair 
phenomena. The zein scaffolds successfully bridge the defects with cartilage but just begin ossification at 
6 weeks post-implantation. Therefore, both scaffolds serve as viable constructs for long bone regeneration 
that is most similar to fracture healing and developmental regeneration.  
 
 
 
5. 2 Future  Work 
 
 
 Even though the initial stages of bone regeneration in the Xenopus Laevis animal model show 
potential using scaffolds and growth factors to ossify critical size defects, there may be plenty of 
improvements made to increase the quality of and speed up the regeneration process. Firstly, regeneration 
times need to be extended up to the completion of ossification in order to entirely assess the quality of 
bone regeneration. Secondly, obtaining information regarding tissue growth and cellular activity at more 
time points and focusing near cut sites can pinpoint the exact biological mechanisms taking place during 
each stage of regeneration. However, the most crucial parameters for change remain the scaffolds and the 
growth factors. There are many choices for scaffold materials, porosity, density, biodegradability, time-
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controlled diffusion etc. There are also many different growth factors that can be used to elicit bone 
regeneration responses. Any of these parameters can be changed to improve the quality and time of 
regeneration. Finally, many animals have been sacrificed in order to study the early stages of bone 
regeneration using histomorphometric methods. Analyzing regeneration results using other non-
destructive techniques such as MRI or Ultrasound can greatly improve experimental methods since many 
animals will be saved and bone regeneration processes can be monitored at longer time points in same 
samples. Therefore, there are many approaches to tackle the issue of long bone regeneration in critical 
size defects and with improving technologies and new information being available in literature,  
noteworthy leaps may be made in the upcoming years for implanting optimal biomaterials into mammals. 
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